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Radiation therapy for cancer now includes several, significantly different techniques. To 
ensure treatment quality, both in terms of safety and efficacy, each technique requires the 
use of numerous, customized devices. This thesis considered two such devices, designed 
at the Centre of Medical Radiation Physics, University of Wollongong, and investigated 
their applications in scenarios that are particularly challenging in modern x-rays external-
beam radiation therapy. 
 
The first device was a metal-oxide-semiconductor field-effect transistor (MOSFET) 
named MOSkin. The MOSkin was first introduced to address the longstanding challenge 
of measuring radiation dose to the skin of a patient. Other existing sensors were not able 
to measure accurately in that context, and calculations with a treatment planning system 
were known to be not adequate. In this thesis, the first step was to look into the MOSkin 
seeking to optimize its design, so that it could be used to measure dose to the skin of a 
patient who requires medical imaging with ionizing radiation. Examples of that imaging 
include image-guided radiation therapy, but also a range of procedures used for diagnostic 
radiology. The second step was to look into the MOSkin as a device to evaluate a novel 
bolus. The bolus can be applied on the skin of a patient during x-rays radiation therapy, 
to provide additional dose build-up and ensure high dose is delivered to the superficial 
regions. 
 
The second device was a two-dimensional monolithic array of silicon diodes named Octa. 
The Octa was first introduced to address the challenge of measuring two-dimensional 
dose distribution, with a spatio-temporal resolution commensurate with stereotactic x-
ii 
 
rays radiation therapy. Stereotactic treatments deliver radiation beams in arcs around the 
patient so, in this thesis, the first step was to look into the sensitivity of the Octa changes 
as a function of radiation’s angle of incidence. This investigation was also necessary to 
prepare for the second step, which looked into the Octa as a quality assurance device in 
the specific case of stereotactic body radiation therapy for vertebral metastases. The Octa 
was considered a good candidate to map the two-dimensional distribution of radiation 
dose across the vertebrae, and surrounding organs at risk such as the spinal cord, 
demonstrating steep dose gradients were delivered to the patient as prescribed. 
 
The present thesis demonstrated that (1) the MOSkin design can be optimized for 
measuring dose to the skin of a patient who requires medical imaging that use ionizing  
radiation and that (2)the MOSkin can be used to evaluate the suitability of novel bolus 
for clinical use. Design optimization was achieved using sensitive volumes of a different 
thickness. The present thesis also demonstrated that (3) the Octa sensitivity to radiation 
is angularly dependent, but that this dependence can be characterized and accounted for, 
and that (4) the Octa can be considered as a good candidate to ensure the quality of 
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According to the World Health Organisation (WHO), cancer is the second leading cause 
for death globally, with the number of deaths about 9.6 million in 2018. At present, there 
are three key modalities for treatment and palliative care, namely surgery, chemotherapy, 
and radiation therapy. The main goal of treatment is to kill or remove the cancer and 
improve the quality of life for patients. In radiation therapy, this can be achieved by 
delivering the correct amount of radiation to the tumour, killing the cancer cells while 
sparing healthy cells. 
Modern radiation therapy uses a combination of small radiation fields to achieve high 
conformity of dose placement. Treatments are performed with medical linear accelerators 
(linacs). For these treatments, to satisfy the need for accurate quality assurance, a silicon 
radiation sensor is often the dosimeter of choice. Silicon dosimeters are based on 
generating of electron-hole pairs that are created when incident radiation beams pass 
through a sensitive volume of silicon and deposit their energy. The amount of charge 
carriers can be measured and is related to the dose deposited in the silicon. Silicon 
dosimeters can be operated in passive mode (no external bias used), or in active mode, 
and have sensitivities 1800 times greater than an ionization chambers of the same volume, 
its cavity filled with air. 
Currently, the diode is the most common silicon structure used for dosimetry. It is 
fabricated on a silicon substrate, doped by adding boron (producing holes to create a p-
type base) or phosphorous (as an electron donor to form n-type base), and then creating a 
p-n junction. It is possible to fabricate small sensitive volumes while retaining high 
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sensitivity, fast signal collection and stable and linear response with accumulated dose 
(Seco et al., 2014). 
Recently, diode dosimeters have been used in radiation therapy to measure relative 
absorbed dose and for verification of dose calculations with a treatment planning system. 
Examples of such dosimeters includes the SFD diode (IBA Dosimetry, Germany) and the 
MapCHEK3, a planar array of diodes (Sun Nuclear, USA). 
There are limitations in using diode dosimeters in small radiation fields. For example, 
their sensitivity to incident radiation varies as a function of instantaneous dose rate, 
particles energy, angle of incidence. 
1.2 Project aims and objectives. 
 
In the present work, the candidate considered two silicon dosimeters designed at the 
Centre of Medical Radiation Physics, University of Wollongong, and investigated their  
potential for addressing the challenges of specific scenarios in modern x-rays external-
beam radiation therapy. 
The first device was a metal-oxide-semiconductor field-effect transistor (MOSFET) 
named MOSkin. After looking into the MOSkin seeking to optimize its design, so that it 
could be used to measure radiation dose to the skin of a patient who requires medical 
imaging that use ionizing radiation, the candidate looked into the MOSkin as a device to 
evaluate a novel bolus called ‘eXaSkin’. Bolus can be applied on the skin of a patient 
during radiation therapy, to provide additional dose build-up; this ensure high dose is 
delivered to the tissue close to the skin. 
The second device was a two-dimensional monolithic array of silicon diodes named Octa. 
The dosimeter has 512 diodes overall, arranged along 4 arrays at 45 degrees with respect 
to each other. After looking into the response of the Octa to incident radiation, and in 
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particular into how that response changes as a function of the angle of incidence, the 
candidate looked into the Octa as a quality assurance device in the case of stereotactic 
body radiation therapy (SBRT) for vertebral metastases. This a particularly challenging 
treatment that use many small radiation beams, shot from several different angles, as the 
linac’s gantry rotates around the patient. The hypothesis was that the Octa is a good 
candidate to map a two-dimensional distribution of radiation dose across the vertebrae, 
and surrounding organs at risk such as the spinal cord, with a high spatial resolution (0.3 
mm). These measurements could demonstrate the steep dose gradients, required to ensure 
high dose to the vertebra but no dose to the spinal cord, are actually delivered to the 
patient as prescribed. 
This thesis consists of eight chapters. Chapter 1 includes the Introduction, the aims, and 
the objectives of this thesis. Chapter 2 describes the current radiation therapy techniques, 
and their quality assurance procedures, including dosimeters most commonly considered 
in the context. The aims of this thesis are then achieved in the following chapters. 
Part 1: the MOSkin, design improvements and applications. 
Aim1: Optimizing the MOSkin for measurements of dose due to medical imaging. 
Research question: is it possible to tune the sensitivity of the  MOSkinTM  and its lifespan for 
measurements of radiation dose due to medical imaging? 
This research question is addressed in more details in Chapter 3. Chapter 3 describes the 
MOSkinTM as a dosimeter. It is operated in real-time with or without external bias and has 
a very small sensitive volume. A MOSkin’s sensitivity to ionizing radiation can be adapted 
to a certain application by fabricating the radiation-sensitive volume with a specific depth 
or by modifying the external bias applied on its gate, during irradiation. However, an 
improved sensitivity causes a decline in the MOSkin‘s lifespan. Chapter 3 then studies a 
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way to increase sensitivity while decreasing lifespan decline. Various MOSkins  were 
used in this study with sensitive volumes of thickness 0.68 μm or 1.0 μm and various 
concentration of boron implantation under the gate of silicon oxide. When irradiating the 
MOSkins with a megavoltage medical linear accelerator (linac) and with orthovoltage x-
ray tubes using various positive biases on the gate; a number of parameters were 
evaluated, such as linearity with dose and sensitivity to photon beams.  
Aim 2: Explore the characteristic of a novel eXaSkin bolus for radiation therapy 
using the MOSkin.  
Research question: does the novel eXaSkin bolus improve the dose delivered to the skin? 
what are the differences in the build-up region using the eXaSkin bolus and water slabs? 
What are the differences in the skin dose and in the central dose under the eXaSkin and 
the alternative commercial Superflab bolus?   
This research is addressed in chapter 4 where the characteristics of the novel eXaSkin 
bolus, a high-density bolus alternative to the commercial tissue-equivalent Superflab, 
were explored by two methods.  
The first method evaluated the density of the eXaSkin bolus by shaping the bolus into 
slabs and calculating the density as function of width, depth, length, and weight; then, 
investigating the build-up dose characteristics of the eXaSkin for 6 MV photon beams, 
using a Varian linac with a field size of 10 x 10cm2. The build-up dose characteristics of 
eXaSkin with thickness 3, 5, 8, 10, 15 and 26 mm were investigated in comparison with 
those of a solid water-equivalent slab of thickness 2, 5, 15, 20 and 26 mm. Additionally, 
percentage surface dose measurements for various oblique incident beams with a 3 mm 
thickness of eXaSkin bolus was also investigated. Measurements were performed using 
a MOSkinTM dosimeter and cross-checked with an advanced Markus ionization chamber.  
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The second method evaluated the eXaSkin for 6 MV radiation therapy clinical plans. The 
density of the eXaSkin bolus was calculated with  a computed tomography (CT) scan, 
and a volumetric modulated arc radiation therapy (VMAT) head-and-neck plan was 
delivered to an anthropomorphic phantom in three scenarios: with no bolus on the 
phantom’s surface, with Superflab, and with eXaSkin. In each case, the dose to a central 
planning target volume (PTV) in the nasopharynx region was measured with an ionization 
chamber, and the dose to the skin, at three different positions within the vicinity of a neck 
lymph node PTV, were measured with a MOSkinTM. Measurements were compared 
against calculations with the treatment planning system (TPS).  
Part 2: the Octa and its applications 
Aim 3: In stereotactic therapy for vertebral metastases, a dosimeter should be able 
to measure dose distribution in the horizontal plane, rather than the coronal plane 
(Figure 1), is much needed. Aim 3 was to design a custom-made phantom to 
accommodate the Octa dosimeter in the horizontal plane. 
Research question: how to design a  phantom suited to accommodate the Octa dosimeter 
in the horizontal plane?  
 
 




This research question is addressed in chapter 5, describing the custom-made design of a 
phantom to accommodate the 2D monolithic array of silicon diodes named Octa. Both 
the spine phantom and the Octa were designed at the Centre of the Medical Radiation 
Physics. This chapter reports on the manufacturing of the phantom with the assistance of 
computer-aided design (CAD) technology. The phantom was fabricated from polymethyl 
methacrylate (PMMA). 
Aim 4: Explore the Octa response as a function of the angle of incidence of radiation 
beams, in a standard cylindrical geometry, with the array measuring in the coronal 
plane (Figure 1). 
Research question: is the Octa response angularly dependent, and if so, is it possible to 
account for that dependence, regardless of radiation field size? 
Based on the literature, it is expected that a planar monolithic array of silicon diodes such 
as the Octa has a sensitivity to incident radiation that varies as a function of radiation 
incident angle. Therefore, prior to using the Octa in the ‘spine phantom’ to measure dose, 
the candidate needed to explore the angularly-dependent response of the array, and also 
investigate if that varies as a function of radiation field size. 
This research question is addressed in chapter 6. This study was performed considering 
open fields of 10x10 cm2, 1x1 cm2 and 2x2 cm2 , all with 6 MV beams. Benchmarking 
was done considering measurements with EBT3 films. 
 Aim 5: Explore the Octa response as a function of the angle of incidence of radiation 
beams, in the custom-made phantom of Aim 3, with the array measuring in the 
horizontal plane (Figure 1).  
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Research question: is the Octa response angularly dependent, and if so, is it possible to 
account for that dependence, regardless of radiation field size? 
 This research question is addressed in chapter 7. Similarly to the previous one, also this 
study was performed considering open fields of 10x10 cm2, 1x1 cm2 and 2x2 cm2 . 
Benchmarking was done considering measurements with a treatment planning system. 
. 
Conclusion: Finally, the last chapter, chapter 8, has final remarks and a summary of 
contributions. 
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One of the requirements of the normal renewal process for tissues in the human body is 
that existing stem cells reproduce themselves to maintain tissue size and function. The 
unlimited proliferative capacity of these cells is the basis of the structure of the normal 
epithelial and haemopoietic tissues of the body (Mayles et al., 2007). Cancer arises if 
there is an uncontrolled manner in which neoplastic stem cells grow, spreading 
cancerously to nearby tissues or to other parts of the body. The aim of cancer radiotherapy 
treatment is to deliver a maximum dose to cancerous cells without affecting the healthy 
tissue nearby. This can be achieved by giving careful attention to the dose distribution 
together with the biological effects of the radiation. The biological effects depend on the 
spatial and temporal distribution dose and on biological response processes. Two 
biological response models, Tumor Control Probability (TCP) and Normal-Tissue 
Complication Probability (NTCP), are used to establish accurate dose distributions. 
Currently, a dose volume histogram is available as a dose shaping tool that can be used 
to choose one of many alternative treatment radiation therapy plans. 
2.2 External Beam Radiation Therapy Treatment (EBRT) 
 
An X-ray linear accelerator (“linac”) is currently the most popular device to treat cancer 
cells with high energy X-rays (Megavoltage range). Therefore, it is required to study the 
penetrating characteristics of such radiation in the patient (Metcalfe et al., 2012).  For 




machines are used for treatment and palliation. These machines do not provide skin 
sparing properties because they using low penetrating photons due to their low energy. 
For more penetrating photons with higher energy, Cobalt-60 machines were introduced 
which have two spectral peaks, 1.17 and 1.33 MeV, with mean energy 1.25 MeV. Photons 
of such energy provide maximum dose at depth of about 0.5 cm in the human body and 
provides skin-sparing. However, higher energy X-ray linacs are more appropriate for  
radiotherapy applications rather than cobalt-60. X-ray linacs have many features such as 
various electron and photon energies that allows the physician to choose the delivered 
energy that is consistent with the requirements for the depth and width of the treatment 
volume.  
Figure 2 and Figure 3 illustrate a modern linac and its component, respectively. There are 
many types of linac for clinical use. Modern linacs are currently available to provide 
photon energies from 6MV to 18 MV and electron energies from 6 MeV to 22 MeV 
(Podgorsak, 2005).  
 
 







Figure 3. Schematics of the components of a modern linear accelerator for radiation therapy 
(Metcalfe et al., 2012) 
The main aim of radiation therapy treatment is to deliver a high dose to a volume of cancer 
cells (target) while minimizing dose to the surrounding healthy tissue to protect the 
critical structures or organs at risk (OAR). The International Commission on Radiology 
Units and Measurements (ICRU) reports numbers 62 and 50 demonstrate the definition 
of the target volume. The target volume is the anatomical volume irradiated by each 
treatment; its margins minimized by delivering the correct dose. The main concepts 
underlying any discussion of target volume are Gross Target Volume (GTV), Clinical 





Figure 4. Schematics demonstrating key definitions in radiation treatment, in particular, the 
gross target volume (GTV), clinical target volume (CTV) and planning target volume (PTV). 
Adapted from ICRU report 50 (ICRU 1993). 
These terms can be defined according to Shang et al. (Shang et al., 2015) as follows: the 
GTV for the head and neck cancer (HNC) patients is “the gross extent of the primary 
tumour and any cervical lymph nodes felt to be involved in imaging or physical 
examination”. The clinical target volume is “the GTV plus a margin for potential 
microscopic spread of disease as well as clinically negative but at risk regional lymph 
nodes”. The planning target volume is “the CTV plus a margin, usually 3-5 mm, 
depending on the image guidance techniques used and the frequency of image guidance 
applied, to account for setup uncertainties”. In radiation oncology, head and neck cancer 
(HNC) radiation therapy is one of the most technically challenging treatment because of 
the number of tumours each with a different treatment dose, and the irregular surface of 
this region.  Intensity modulated radiation therapy (IMRT) and volumetric modulated arc 
therapy (VMAT) are the most common techniques for HNC treatment (Shang et al., 
2015). In radiotherapy, image guidance usually accompanied by each radiation treatment 
to achieve a high-quality result. Over time, image guidance has progressed from weekly 
two-dimensional (2D) portal imaging to three-dimensional computerized tomography 




         Three-dimension conformal radiotherapy (3D-CRT) was developed in 1980 to 
eliminate the need for any additional surgical procedures and to improve dose 
homogeneity in the target volume. This method needs a 3-D view of the target object and 
it is composed of two opposed lateral (bilateral) fields and a third anterior field (Metcalfe 
et al., 2012) (Figure 5). The two fields of 3D-CRT for HNC treatment are applied to 
irradiate a primary tumour and cervical lymph nodes in the upper and lower neck. The 
third field is applied to irradiate the supraclavicular lymph nodes. In order to avoid field 
overlaps at the field junction line, all these fields are matched at the isocentre plane (Shang 
et al. 2015).  
 
Figure 5: 2D projection of unmodulated coplanar or non-coplanar beams for 3D-CRT. 
(Metcalfe et al., 2012) 
From 1990, Intensity modulated radiotherapy (IMRT) was used to reduce the intensity of 
rays that are delivered to sensitive critical structures and to increase the received dose of 
these rays in the target volume. Thereafter, the modulation of the intensity of radiation 
beams could be used to produce a high conformity of the dose distribution with the target 





 Figure 6. Schematic illustration of the intensity modulate radiation therapy technique (Brahme, 
1988). 
There are two modes in IMRT. The first mode is the “dynamic” mode or “sliding 
window” mode, where the beam is on and the mechanical parts are moved  (Kijewski et 
al., 1978). The second mode is the Step-and-Shoot mode, where the beam is off, and the 
MLC moving.  Palma et al. (Palma et al., 2010) observed a major difference between the 
delivery time of the IMRT technique and the 3D-CRT, which could be in the range of 15 
to 30 minutes for the IMRT whereas for the 3D-CRT delivery time could be just a few 
minutes. 
In 2007, volumetric modulated arc therapy (VMAT) was introduced where the gantry is 
rotated around the patient while the beam is on. Three parameters can be changed during 
VMAT: the beam shape, the rotation speed, and the dose rate. The main properties of 
VMAT are that: (i) the radiation beam can be delivered by a conventional linear 
accelerator (linac);(ii) a single rotation of VMAT can deliver the dose to the target and 
the dose distribution can be improved by using another rotation (Palma et al. 2010). Thus 
far, a number of studies (White et al., 2012, Verbakel et al., 2009, Tol et al., 2015) have 
shown that the VMAT plan for HNC is composed of 2-3 full or partial arcs depending on 
the target site (bilateral or unilateral). Gomez-Millan et al. (Gomez-Millan et al., 2015) 
and Osborn (Osborn, 2017) demonstrated the benefit of VMAT for head and neck cancer 




delivery time and lower integrated dose to the body than the IMRT technique. Shang et 
al. (Shang et al., 2015) reported that the VMAT technique is very suited to multileaf 
collimators (MLCs) and gantry motion when the beam is on and can gain from 
implementations capable of simultaneously modifying MLC speed, dose rate and gantry 
speed. 
Tomotherapy (i.e., slice therapy) is the rotation of a radiation source through 360° when 
a patient’s body is moved through the radiation field. The radiation beam is delivered in 
a fan-shape where the radiation beam is adjusted as the beam rotates (Figure 7). There are 
two main techniques for tomotherapy: axial or serial tomotherapy and helical 
tomotherapy. Axial tomotherapy is defined as the radiation beams being delivered slice 
by slice, so the radiation beams treat a slice of the tumor before the patient’s body is 
moved ready for the radiation beams to treat the next slice of tumor area. Helical 
tomotherapy has the radiation beams being delivered in a continuous spiral and modulated 
by a binary MLC with the patient’s body being moved continuously during the treatment 
(Oliver et al. 2009).    
  




 Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT) deliver a 
high dose 8-24 Gy in a single fraction or 40-50 Gy in multiple fractions in a small field 
to an inoperable tumour where surgery is not possible. In a study that investigated linac-
based stereotactic radiotherapy techniques for treating pituitary adenoma and 
craniopharyngioma, Varghese et al. (2018) reported that SRT techniques which include 
static conformal fields (SCFs), static conformal arcs (SCAs) and dynamic conformal arcs 
(DCAs) have delivered an accurate conformal and homogeneous dose to tumours with a 
minimal delivered dose to healthy adjacent structures. 
2.3 Quality assurance (QA) in radiotherapy  
 
Quality assurance (QA) in radiotherapy involves all the procedures that are followed to 
verify that the desired treatment has been administered, ensuring delivery of an accurate 
high dose to the cancer and a minimal dose to the normal tissue. In order to measure or 
predict the absorbed dose in tissue, there are two steps (Figure 8). The first step is 
providing a suitable patient “phantom” to assess the deposited dose in human tissue. This 
phantom should be radiologically similar to the human body and its density. There are 
many types of phantom such as “slab” phantoms of layered solid water-equivalent 
materials and “anthropomorphic” (human-shaped) heterogeneous phantoms. The second 
step is to measure the deposited dose with a suitable dosimeter at a specific location in 
the phantom. From the collected data, mathematical algorithms for the treatment planning 





Figure 8: Setup for dosimetry of external radiation therapy  (Metcalfe et al., 2012) 
 
There are many types of dosimeters that are applied in radiation therapy such as 
1- Ionization chambers (parallel-plate, cylindrical ...etc.) 
2- Thermoluminescent dosimeters (chips, powder...etc.) 
3- Radiochromic films 
4- Silicon dosimeters 
5- Diamond dosimeters 
6- Fibre optics dosimeters  
Ionization chambers are the most common dosimeters that are applied in radiotherapy and 
are considered as a reference standard for other dosimeters such as MOSFETs.  Therefore, 
there are many QA reports published by various organizations and researchers outlining 
procedures to be followed in radiotherapy treatment steps to ensure delivery a high dose 
to the tumour and a minimal dose to the healthy tissue, such as the American Association 
of Physicists and Medicine (AAPM TG-40) Report in 1994. 
2.4 Dosimeters 
 




2.4.1 Ionization chambers 
 
There are many types of ionization chambers depending on their geometry, materials, the 
thicknesses of their walls, electrode materials and active interaction volumes (typically 
air is used as a filling medium). Figure 9 illustrates the main components of parallel plate 
ionization chambers where the filling medium is gaseous.  
 
Figure 9: Illustration the components of the parallel-plate ionization chamber. 1-The polarizing 
electrode, 2-the measuring electrode, 3-the guard ring, a- the height (electrode separation) of the 
air cavity, d-the diameter of the polarizing electrode, m-the diameter of the collecting electrode, 
g-the width of the guard ring. (Podgorsak 2005) 
 
The main type of parallel plate ionization chamber is the Markus ionization chamber. It 
consists of two plane walls, the first one acting as an entry window and polarizing 
electrode and the second a collecting electrode, which also functions as a back wall. The 
“guard ring” also an important part of an ionization chamber, since it provides a 
homogeneous electric field between the two electrodes. The thickness of the guard ring 




radiation beams are penetrating the dosimeter, the impact of radiation on the air cavity of 
the chamber could be described as in Figure 10.  
 
Figure 10: Chain of events after impact of an incident photon in the air cavity of an ionization 
chamber(Metcalfe et al., 2012) 
Kerma (kinetic energy released per unit mass) is proportional to the photon energy fluence 
in any homogeneous material such as air. Secondary electrons are produced when primary 
incident photons interact with the air, and a certain amount of energy is transferred during 
Compton interactions. Collisional Kerma is related to kinetic energy of electrons 
deposited to ionization in matter while part of kinetic energy of secondary electrons are 
losing their energy through as bremsstrahlung (Radiative KERMA). The resulting ions 
which are produced are collected in ionization chamber and measured by an electrometer. 
Two types of Markus ionization chamber are now in frequent use: a classic Markus 




details of the classic Markus chamber and the advanced Markus chamber as illustrated in 
Figure 11 (from Von Voigts-Rhetz et al., 2017).   
Table 1: Geometric details of classic Markus and advanced Markus ionization chamber (Von 
Voigts-Rhetz et al., 2017) 
Chamber                                           v(cm3)            r(cm)          h(cm)         w(cm)         d(cm) 
Classic Markus (PTW-23343)              0.055          0.265         0.2              0.035          0.13 
Advanced Markus (PTW-34045)         0.020           0.25           0.1              0.2              0.13 
Where: 
1. v  is the active chamber volume. 
2. r   is the radius of the active volume. 
3. h  is the height of active volume. 
4. w  is the width of the guard ring. 
5. d  is the thickness of the dose entrance window. 
 
Figure 11: Illustration of the outer dimensions of an a) advanced Markus and b) classic Markus 
ionization chamber. (von Voigts-Rhetz et al., 2017) 
   An advanced Markus parallel-plate ion chamber type 34045 (PTW, Freiburg, Germany) 
was used for the surface dose and build-up region measurements described in this thesis. 




diameter of the wall is 9 mm, whereby the scattered electrons are produced from the 
sidewall and are measured in the active volume of the chamber.  
In a comprehensive study of doses measured by ionization chambers, Velkley et al., 
(Velkley et al., 1975)   introduced correction factors for electrons that are produced from 
the sidewall of the chamber and cause perturbations in dose measurements. Gerbi and 
Ghan (Gerbi and Ghan, 1990) reported that Velkley correction factors are valid for 
chambers that have 5-11 mm distance between the collecting edge and the sidewall. In a 
study conducted by Rawlinson et al. (Rawlinson et al., 1992), it was found that an over-
response in readings of plate parallel ionization chambers is dependent on the design 
features of the chamber. The design of the advanced Markus chamber is different from 
the original Markus chamber and has an overresponse correction factor of 3.3%, while 
the overresponse correction for the original Markus is 10.1%.  
Therefore, Rawlinson has modified the Velkley correction formula as follows: 
P(d, E) = P’(d, E, G) – ξ (d, E, G)                            (2.1) 
ξ (d, E, G) = ξ (0, E, G) x e-4.0d/dmax                           (2.2)    
ξ (0, E, G) = c (E) x (s/w) x ρ0.8                                (2.3) 
Where: 
1. P  is the true PDD. 
2. P’  is the measured PDD. 
3. ξ    is an over-response correction factor. 
4. E   is the beam energy. 




6. ρ   is the mass density of the ionization chamber wall. 
7. s/w is the ratio of electrode separation (s) to the inner diameter of the sidewall (w) 
For E = 6 MV photon beam energy , dmax =15 mm and c (E) = 0.27 (Rawlinson et al., 
1992).  
Another type of ionization chamber, the Octavius 1000SRS, is a 2D array of ionization 
chambers consisting of 977 ICs (SVs) with 2.5 mm pitch in the 5 cm2 central area and 5 
mm pitch outside this area. It was used for small field dosimetry and the main 
characteristics include high accuracy and sensitivity (Loutfi-Krauss et al., 2017).  
2.4.2 Radiochromic films 
 
Radiochromic films perform two-dimensional (2D) dosimetry. They are used to measure 
a dose range between 50Gy to 2500Gy in external radiotherapy (Devic et al.,2006). 
Currently, Gafchromic brand EBT film is used in external radiotherapy. The main 
characteristics of this film are it is independent of beam angle, dose rate and energy; it is 
insensitive to visible light, it has high spatial resolution, and it does not need processing 
because it is self-developing once exposed to radiation. Wen et al. (Wen et al., 2016) 
provide a useful explanation of practical and efficient protocols for using Gafchromic 
EBT3 film in SRS and SBRT to obtain absolute dose values. However, radiochromic 
films require densitometry measurements and calibration of the densitometer to obtain 
the relationship between the films’ measured optical density and the original delivered 
dose.  
2.4.3 Silicon dosimeters 
 
Figure 12 illustrates the schematics of a MOSFET, a Silicon dosimeter that, at present, is 
typically used in radiation therapy to measure the radiation dose on surface or in the build-




several valuable features. They provide an immediate readout, have a small size and a 
good spatial resolution.  The process of producing a signal occurs when the incident 
radiation photon penetrates the oxide gate of the MOSFET which causes generation of 
charges, which are trapped permanently at or near the SiO2/Si- substrate interface, causing 
an alteration in the threshold voltage (Vth).  Alteration of the Vth is proportional to the 
absorbed dose. However, MOSFETs have a limited lifespan, specific to a given read-out 
system. 
 
                            
             Figure 12. Illustration of the components of a MOSFET (Metcalfe et al., 2012) 
 
A new MOSFET dosimeter, the MOSkin, was designed by the University of Wollongong; 
Centre for Medical Radiation Physics (CMRP). The MOSkin can provide a very accurate 
measurements for skin dose because MOSkins can measure dose at a depth of 0.07mm, 
in accordance with the International Commission on Radiological Protection (ICRP) 
recommendation for radiosensitive basal layer measurements. Figure 13 illustrates the 




There are many other different silicon dosimeters used in radiation therapy dosimetry. 
For instance, silicon diodes. Examples of that are the SFD diode (IBA Dosimetry, 
Germany) and the Razor diode. They  consist of a small sensitive volume of 0.6 mm 
diameter. A common characteristic of all these devices is that they provide a simple, 
convenient, linear conversion of dose to measured electrical charge, but they all have 
varying degrees of (small) over-response when used in small field dosimetry (Garnier et 
al., 2018; Tyler et al., 2013 & Liu et al., 2016).  
 
Figure 13. MOSFET and MOSkinTM designs: a) MOSkin system b) Design of MOSFET with an 
epoxy bubble encapsulation above the sensor c) MOSkin being operated in a “face –up” 
orientation d) MOSkinTM being operated “face down”. (Safari et al., 2015). 
 
There are now many types of the silicon dosimeters arrays available, but an important 
issue with the dosimeter arrays is their angularly dependent response. The “dose 
magnifying glass” (DMG) is a one-dimension array silicon dosimeter. It consists of 128 




IMRT QA and SRS small field dosimetry. The angular dependent response of DMG on 
PCB is 28% which is reduced to 12.8% when the DMG is mounted on a Kapton pigtail. 
The MapCheck3 (Sun Nuclear Corporation, Melbourne, FL, USA) is a commonly used 
two-dimensional array silicon dosimeter. This dosimeter is configured from 1527 n-type 
diodes spread over an area of 0.64 mm2 with 7.07 mm  spacing. This dosimeter is designed 
for VMAT QA and it response exhibits a good match with TPS plans at different photon 
energies 6, 8, 10 and 15 MV (Low et al., 2011).  Another 2D dosimeter is the SRS Profiler 
which  has 125 diodes spread over four arrays (two orthogonal and two diagonals). The 
CMRP has been developed several two-dimensional silicon array dosimeters including 
the Magic Plate 512 (MP512), the DUO. The MP512 and Duo were the first generation 
of monolithic silicon dosimeters arrays. The MP512 was designed with 2 mm pitch that 
can exactly reproduce the penumbral region (Alrowaili et al., 2017). Its angular dependent 
response could be corrected for use in small field dosimetry. The DUO dosimeter was 
designed with two orthogonal arrays having 505 diodes in each array, spread over an area 
of 52x52 mm2 with 0.2 mm pitch (AlShukaili et al., 2018).  
The Delta4 (ScandiDos AB, Uppsala, Sweden) and the ArcCHECK (SunNuclear 
Corporation, Melbourne, FL, USA) are three-dimension commercial dosimeters. The 
Delta4 consists of 1069 cylindrical p-type diodes (each diode has a 0.05 mm thickness 
and 1 mm diameter), arranged on orthogonal plane and embedded into a cylindrical 
phantom. The ArcCHECK consists of 1386 n-type diodes with a 1 cm pitch on a HeliGrid 
and the dimensions of each diode are 0.8 x0.8 x0.03 mm3 embedded within a cylindrical 
phantom of PMMA with a central air cavity. Both the dosimeters have been used for small 
field dosimetry.  





An ideal accurate dosimeter is one of the quality assurances tools for use with small field 
beams. The main requirements for an ideal dosimeter are to be water equivalent,  having 
a small sensitive volume, be energy and dose-rate independent and allow a real-time 
readout system. Accurate small field dosimetry can produce an accurate verification of 
dose distribution predicted by TPS, and this leads to significant positive outcomes for 
patients (Biasi, 2018).  The ICRU (ICRU report 91, 2017) and the IAEA (IAEA-TRS-
483, 2017) have been demonstrated the challenges accompanying quality assurance in 
small field dosimetry. These are challenges such as partial occlusion of the primary 
source, loss of charge particle equilibrium (CPE) on the central axis and dosimeter 
dimensions relative to the field beam dimensions which affects the particle spectra. The 
effects lead to overlapping the penumbrae of the primary beams over the dosimeter 
volume and produce inaccuracy in the dosimetry readings (Andreo, 2018).   
The angular dependence of silicon arrays has been reported to be the main drawback of 
silicon dosimeters because of the materials in the dosimeter sensitive volume and the 
dosimeter assembly (Stansook et al., 2017). The secondary electron spectrum in a 
sensitive volume depends on the angle of radiation beam which determined by it 
packaging. This angular response of the dosimeter limits the accuracy in small field 
dosimetry.  
2.6 Skin dose and build-up region characteristics of X-ray 
  
 The absorbed dose in the skin region alters rapidly, and the alteration is dependent on the 
photon beam energy, beam geometry, and electron contamination. The surface dose for 
high-energy photons is lower than the maximum dose at depth (dmax), and that is known 
as “skin sparing”. The International Commission on Radiation Units and Measurements 




that 0.07 mm is the depth of measurement for  skin dosimetry where the basal layer is 
located because it is considered to be one of the most radiation -sensitive layers. 
X-ray photon beams include not just the primary photon that are produced from the linac 
but also include electrons. When X-ray photon beams strike modifying devices such as 
collimators, blocking trays and exit jaws, the generated electrons contaminate the column 
of the air between the head of the linac and the patient. Therefore, the surface dose comes 
from the primary photons, the electron contamination and the backscattered photon 
interactions as shown in Figure 14 (Metcalfe et al., 2012). 
 
                 Figure 14: Electron contamination of a primary X-ray beam (Metcalfe et al., 2012). 
 
When the primary beam penetrates the patient to generate surface dose (Ds), high energy 
x-rays and electrons interact with the patient (or phantom in a simulation) to produce the 




gradually until it reaches the maximum dose (Dmax) at a depth called dmax (Figure 15). The 
dose after Dmax decreases exponentially until it reaches the exit dose (Dex) at the depth 
(dex). The curve comprising the sum of all these processes is called the “percentage depth 
dose” (PDD) curve, wherein all doses at different depths are normalized to Dmax and 
multiplied by 100 (Podgorsak, 2005).  
 
                                        Figure 15: Percentage depth dose (PDD) (Podgorsak, 2005). 
 
In Megavoltage X-ray beams, charged particles travel in the phantom or patient and 
deposit amount of energy along their tracks; the absorption of this energy does not 
necessarily occur at the same interaction site. Absorbed portion of energy is known as 
“collision Kerma” in case of charge particle equilibrium (CPE).  Charged particle 
equilibrium is attained when the energy transferred in and out of a certain volume by 
charged particles is equal, so the condition of CPE does not exist at every depth under the 
skin surface. The absorbed dose in the build-up region is smaller than collision Kerma. 
At d=dmax the number of electrons reaches longitudinal equilibrium and CPE becomes 




photons by attenuation and scattering. The collision Kerma and the dose in this area 
decrease, and this is called transient longitudinal equilibrium (Figure 16). 
 
 
Figure 16: Illustration of the conditions related to CPE:  a) CP disequilibrium b) Transient CPE 
(Metcalfe et   al., 2012). 
 
By using beam modifying devices such as blocking trays and wedges with different beam 
energies and field size, their effects on the percentage surface dose and build up region 
was investigated by using different dosimeters (Kim et al.1998, Lamb and Blake 1998, 
Butson et al. 1996, Kron et al. 1993 and Nilsson and Sorcini 1989).  
Various phantoms and dosimeters have been used to evaluate the surface dose and build- 




2000) investigated the surface dose at chest wall (breast) by using a hemicylindrical solid 
water phantom with a 7.5 cm radius and three dosimeters: a GaF film (effective depth 
0.17 mm), thin TLD (effective depth 0.14 mm) and a MOSFET device (effective depth 
0.5 mm).  The phantom irradiated with 6MV X-ray, at 100 cm source surface distance 
(SSD), with field sizes of 20 x 20 and 10 x 20 cm2. Various beam incidence angles were 
used from 0 to 180º to obtain a surface dose profile with 10º increments around the 
circumference of the phantom. The surface dose at 0º and 90º was found to be, 
respectively 28 % and 58 % of dmax by using GaF film, 30 % and 57 % by using TLD and 
43 % and 62 % by using MOSFET. The differences in results were attributed to the 
effective depth of measurement for each dosimeter.  
An optically stimulated luminescence dosimeter (OSLD) ( Yusof et al.2015) was used to 
measure surface dose in a slab phantom and in a breast phantom in comparison with in 
the clinical measurement of 10 patients during tangential breast treatment. The surface 
dose of the treated breast or chest wall and on the contralateral breast during tangential 
breast radiotherapy was evaluated. It was demonstrated that the water equivalent depth 
(WED) of the OSLD is 0.4 mm. The study used the OSLD, a Markus ionization chamber 
and Gafchromic EBT3 film to measure surface dose on a solid water slab phantom. The 
measured surface dose normalised to dmax, was 15.95 %, 12.64 % by the Markus ionizing 
chamber, 23.79 %, 17.14 % by the EBT3 film and 37.77 %, 25.38 % by OSLD for 6 and 
10 MV, respectively. For the surface incident beam, the surface dose increases when the 
incident beam angle increases as expected. For all measurements on the breast phantom 
and on a patient OSLD measured always higher dose than by EBT3 film. Another study 
evaluated the surface and build-up region doses (Akbas et al. 2016) for 6 MV and 15 MV 
photon beams by using three dosimeters; a Markus ionization chamber, EBT3 film and a 




angles 0°, 30°, 60° and 80° and different field sizes 5 x 5, 10 x 10 and 20 x 20 cm2. The 
surface dose measured for 6 MV photon beam and field size 10 x 10 cm2 by the Markus 
chamber was 20.3 %, 18.8 % by the EBT3 film and 25.5 % by the MOSFET dosimeter. 
For 15 MV photon beam and 10 x 10 cm2 field size, the surface dose was 14.9 % as 
reported by the Markus chamber, 13.4 % by the EBT3 film and 16.4 % by the MOSFET 
dosimeter. The surface dose encountered at different incidence angles were investigated. 
It was demonstrated that surface dose is increasing when the field size and/or the 
incidence angle of the radiation beam was increased. 
Numerous studies were carried out to derive correction for measured skin dose assuming 
reference depth is 0.07 mm. Devic et al (Devic et al.,  2006) determined skin dose by 
using radiochromic film for 6 MV x-ray beams. The study included using three types of 
GAFCHROMIC dosimetry film, HS, EBT, and XR-T. These dosimeters measured the 
dose at WED larger than 0.07 mm, and required 15-16 % correction to adjust readings to 
the dose at 0.07 mm. Furthermore, the study used an Attix parallel –plate chamber and a 
home-built extrapolation chamber to measure the dose in the depth range of 4 µm to 1 
mm. The results showed the PDD increased from 14 % to 43 % by using 6 MV photon 
beam with a field size of 10 x 10 cm2 in the first millimetres of the skin region confirming 
that thickness of the sensitive volume of the dosimeter and its packaging are critical for 
accurate skin dosimetry at depth 0.07 mm. The study demonstrated an effective procedure 
that used GAFCHROMIC EBT to get an accurate measurement of the skin dose in a 
parallel-opposed pair 6 MV beam arrangement. The surface dose for IMRT fields has 
been evaluated by using an advanced Markus ionization chamber (Chen et al. 2010). To 
measure the surface dose at depth 0.07 mm accurately by using an advanced Markus 
chamber, an extrapolation method was used by adding a single layer polymer protector 




field size was found to be 19.8% for the open field and 19.2 % for the unmodulated step 
and shoot (SS-IMRT) field.  
Kwan et al. (Kwan et al. 2008 & Jong et al. 2014) reported that a new MOSFET based 
dosimeter, the MOSkin, could provide accurate measurements of the skin dose in 
radiotherapy. The MOSkin is used to measure the skin dose at an equivalent depth of 0.07 
mm and the MOSkin measurements revealed an excellent agreement with the Attix 
chamber in a 6 MV photon beam of various field sizes. The main advantages of this 
dosimeter are that it can measure dose at 0.07 mm, its small size, and its real-time readout. 
The characteristics of MOSkin dosimeter have been extensively evaluated, including 
reproducibility, linearity, and the response for different dose rates at different gate bias. 
A Markus ionization chamber and EBT3 film was also used to measure the surface dose 
and then to compare their results with the MOSkin results (Jong et al. 2014). 
A MOSkin dosimeter was used to evaluate the increase of skin dose during  megavoltage 
X-ray beam irradiation (Alnawaf et al. 2012). The outcomes revealed the MOSkin has a 
minimal effect on increasing the measured skin dose under the detector (the device has 
0.25 mm total thickness) in comparison with TLD. The maximum percentage skin dose 
measured with the MOSkin was 15 % and 10 % with field size 10 x 10 cm2 for 6 and 10 
MV photon beam, respectively. Furthermore, the skin dose measured by the LiF TLD 
technique (1mm thickness) was measured to be 32 % and 26 % for 6 and 10 MV, 
respectively.  
The skin toxicity was observed for head and neck patients treated with IMRT, Lee et al. 
(Lee et al., 2002) suggested that the reasons for skin toxicity for head and neck patients 
who were treated with IMRT might be; the bolus effect of the masks commonly used, the 
use of multiple oblique incident beams and the skin being considered as part of the target 




three delivery techniques for head and neck treatment with: bilateral field, IMRT, and 
tomotherapy as a percentage of the dose in a target. The results revealed that surface dose 
for IMRT was the highest at 82% then tomotherapy at 71 % and finally bilateral fields at 
69%. 
Conversely, Dogan and Glasgow (Dogan and Glasgow, 2003) attributed the increase in 
the skin dose for IMRT not to the IMRT technique itself, but instead found that the surface 
dose for 6 MV IMRT at 0º and 75º incidence angles were lower for (1.6-8.8) % than the 
measurement under the open field depends on a field size. In both cases dose 
measurements were done at depths 2 and 5 mm by using the parallel-plate ionization 
chamber at the same angles of the beam incidence. However, Yokohama et al. 
(Yokohama et al. 2004) found that at 2 mm depth, the skin dose in the IMRT field was 
lower than of the open field by 10 %.  
2.5.1 The effect of immobilization devices and bolus materials on skin dose 
 
In head or neck radiotherapy, the head immobilization devices (head mask) and bolus 
materials significantly enhance the skin dose. A bolus could be considered as a build-up 
material when the clinician is concerned about a near- surface recurrence. Mutic and Low 
(Mutic and Low,2000) and Hsu et al., (Hsu et al.,2008) evaluated the superficial depth 
dose distribution from serial tomotherapy treatments of geometric target volumes. In the 
Mutic and Low study (Mutic and Low, 2000); the differences between the calculated and 
the measured dose were determined and provided insight into the need for bolus on 
superficial target volumes by using a commercial computer-controlled treatment planning 
and delivery system. A cylindrical target volume with 5 cm diameter and 5 cm long  was 
embedded in a water-equivalent cylindrical phantom with dimensions of 16 cm diameter 
and 12 cm long. TLD chips with dimensions 3 x 3 x 1 mm2 were used to measure doses 




calculated doses were slightly lower than the measured doses where the measured dose 
in the build-up region required the use of a bolus to deliver the prescribed dose to the 
phantom surface. Thermoplastic masks with 0.25 cm and 0.4 cm diameters of holes were 
used to assess their impact on the build-up region for 6MV and 15 MV (Póltorak et 
al.,2016). The surface dose for 6 MV was increased from 10 % to 42 % and for 15 MV 
was increased from 5 % to 28 % when using a mask.   
Also, the effect on the skin dose and build-up region of immobilization devices and beam 
modifier has been investigated (plaster and thermoplastic casting materials) , for example, 
the study by Fiorino et al. (Fiorino et al., 1992) used immobilization plastic masks for 
head and neck radiotherapy with megavoltage photon beams radiation. In their study, the 
effect of filters, wedges, and blocks between the patient and the accelerator on the skin 
dose was evaluated. Moreover, the effect of using 2 and 3.2 mm of plastic material on the 
skin dose for head and neck irradiation patients with 6 MeV X-rays was measured by a 
NE2534 chamber (Markus type) on a polymethylmethacrylate (“PerspexTM”) phantom. 
Fontenla et al.( Fontenla et al., 1994) used a polystyrene phantom irradiated with 6 and 
15 MV photon beams at two different source-to-phantom distances and various field sizes 
. They found that 79 % of the maximum dose was delivered when 3 mm solid 
thermoplastic casting material was used with 6 MV and 12 x 12 cm field size, while only 
22% of the maximum dose was encountered when no beam modifiers or immobilization 
devices were used.  
Many studies have investigated the effect of techniques used to deliver  doses to tumours 
with a build-up bolus interposed. The reasons for severe skin reactions for head and neck 
patients who received IMRT have been investigated (Lee et al., 2002). The skin dose 




when the skin is considered as part of the target volume and multiple oblique incident 
beams are applied.  
 Another study measured the skin dose in a phantom in the presence of patient 
immobilization devices by applying EBT film during 6 MV conventional and 6 MV, 15 
MV IMRT treatments (Chiu-Tsao and Chan, 2010). Several different 
immobilization/support devices were applied, namely: an OrfitTM carbon fibre base plate, 
a carbon fibre grid with a MylarTM sheet, Styrofoam, Alpha –CradleTM and perforated 
AquaPlastTM sheet, were used. In this study, the 2D skin dose distribution, isodose curves, 
and cross-sectional profiles at the surface with or without the immobilization/support 
device were determined. Significantly, the 2D bolus effect on skin dose with EBT film 
was evaluated in the presence of immobilization/support devices in vivo. Lee et al.,( Lee 
et al. 2002)  investigated the effect of a technique used for head and neck cancer patients 
who were treated with multiple tangential extended-field intensity modulated 
radiotherapy (EF-IMRT) through a thermoplastic mask. An anthropomorphic RandoTM 
phantom and six TLDs were used to measure the skin doses with and without a mask. The 
dose volume histogram (DVH) of multiple tangential EF-IMRT was compared with the 
DVH of conventional opposed-lateral fields and four alternative IMRT plans were 
produced. IMRT plans that contoured neck nodes up to and containing skin surface were 
compared with plans that contoured neck nodes 5 mm away from skin dose. Similarly,  
IMRT plans that defined the skin as a sensitive structure and the plans that did not define 
the skin as a sensitive structure were also compared. The results showed that the skin dose 
with the mask was higher than without a mask in all four plans. Multiple tangential EF-
IMRT plans exhibited an increasing skin dose of 27 % with the mask and 19 % without a 
mask. The optimization plans programmed to regard the skin as a sensitive structure 




A number of effects that accompany surface doses when using different bolus materials 
for conventional and the intensity modulated radiation therapy (IMRT) tangential fields 
have also been explored (Hsu et al., 2008). In this study, three different types of bolus 
material were used namely: 2mm solid, 3.2 mm large mesh and 2mm fine mesh 
AquaplastTM. They compared these with SuperflabTM. An Attix chamber in a flat solid 
water-equivalent phantom was used to measure the surface dose at 0º, 45º and 70º 
incidence angles. Therefore, for those specific angles, over-response correction factors 
could be calculated and applied to the Attix parallel plate chamber results.  An 
anthropomorphic phantom and a TLD extrapolation method were used to measure  
surface dose. The differences in the surface doses were found to be insignificant between  
conventional and IMRT tangential fields, while the bolus effect for 2mm fine mesh 
Aquaplast was large, up to an 82 % increase for chest wall tangential radiotherapy.  
 In another study for Aquaplast thermoplastic was used as a bolus during treatment of 
superficial lesions on an irregular surface (Huang et al., 2006). Aquaplast RTTM 
thermoplastic is a type of equivalent tissue bolus that can be moulded and located on 
irregular surface. The authors concluded that Aquaplast RTTM thermoplastic bolus is 
helpful in delivering a sufficient dose to skin cancer. The effect on surface dose of using 
various bolus materials  by using a 10 mm thick Vaseline bolus, a 3mm Superflab bolus 
and a brass mesh bolus for 6 and 15 MV photon radiotherapy has been explored by 
Ordonez-Sanz et al. (2014). Solid water-equivalent and anthropomorphic phantoms with 
an ionization chamber and TLD dosimeters were used to study this effect. The results 
showed that the brass mesh bolus increased surface dose with only a slight effect on the 
depth dose curve (DDC) (Al-Rahbi et al 2018). 





Radiotherapy treatment planning (RTP) or a treatment planning system (TPS) is the 
process of  setting a program of treatment instructions aimed at delivering a pre-defined 
dose distribution in the patient as determined by an algorithm. Inaccuracies in the TPS 
when calculating surface dose during radiotherapy have been studied and attributed that 
to the lack of a build-up region near surface (Jong et al., 2016, Fraass et al., 1998, Court 
et al., 2008, Panettieri et al., 2009, Chakarova et al., 2012, Akino et al., 2013). Several 
studies compared doses calculated by treatment planning systems for various techniques 
with doses measured by dosimeters to verify the skin dose.  
  The MOSkin was designed for accurate measurements in skin dosimetry. The in vivo 
skin dose measurements for this new dosimeter were verified by comparison with plane-
parallel ionization chambers and radiochromic films  (Qi et al., 2009). The accuracy of 
the treatment planning system (TPS) for skin dose was evaluated by the IMRT of 
nasopharyngeal carcinoma. The surface and build-up region dose measurements using the 
new dosimeter agreed with an Attix ionization chamber and radiochromic film 
measurements, even for oblique incident beams while the difference from TPS 
calculations were within measurement uncertainty. 
Another study compared between different TPSs.  Pinnacle TPS and Eclipse TPS for the 
breast with a bolus layer were compared (Masunum et.al. 2016). The bolus thicknesses 
tested were 5 mm and 10mm with 200 cGy total doses to the breast. The two algorithms 
provided two plans using a tangential field technique with a 6 MV photon beam. TLD 
was used and calibrated with a Co-60 source. The results showed agreement in the build-
up region for both algorithms. However, for lungs, there was an overestimation by the 
Eclipse TPS with differences of 13.78 % and 6.06 % for both bolus thicknesses 
respectively when controlled by the Pinnacle TPS, while TLD results showed a slight 




 Chung et al. (Chung et al.,2005)  conducted experiments to determine the dosimetric 
discrepancies in the surface and build-up region between the TPS prediction and the 
experimental measurement by using radiochromic film on a head and neck compression 
phantom. Two commercial TPSs were generated (PINNACLE and CORVUS) for two 
cases, shallow and deep targets (0.5 cm and 6 cm depth) with 54 Gy prescribed dose. For 
each case, two pieces of radiochromic film were used, one on the surface and the other 
inserted into the phantom. The results showed that there was a good agreement for both 
TPSs with the measured doses but there were significant discrepancies from the surface 
to about 0.2 cm in depth for both cases. 
 The skin dose for head and neck patients who were treated with tomotherapy monitored 
by using MOSFET and TLDs has also been evaluated (Kinhikar et al., 2009). The skin 
dose in the tomotherapy treatment planning system was found to be overestimated by 
about 10-20 % when compared with MOSFET and TLD readings. 
2.7 Verification of dose with Monte Carlo simulation 
 
Modern particle physics Monte Carlo (MC) methods are deemed an acurate tool for dose 
estimation in radiotherapy. The MC method can be used to characterize the particle 
movements transport inside a material and explore different physical effects such as 
interaction and number and types of secondary particles. The GEANT4 (GEmetry ANd 
Tracking 4) software package is a Monte Carlo simulation Toolkit that can be use it for 
modeling the interactions and transport of particles within matter (Guatelli et al., 2011). 
GEANT4 is used a collection of C++ classes in the GEANT4 collaboration. In 
radiotherapy applications, it is employed to verify dose in TPSs and to improve various 
dosimeters characteristics when used in experimental measurements (Scott et al., 2008; 





Part 1- The MOSkin dosimeter 
 
 
The MOSkin dosimeter is a MOSFET-based dosimeter and packaging designed at Centre 
for Medical Radiation Physics to measure skin dose. The MOSkin packaging design is, 
according to Kwan (2009): “The MOSFET sensor is dropped into a thin layer of Kapton 
and hermetically sealed with a water-equivalent flexible polyimide film of highly 
reproducible thickness”. The film functions are to protect the electronics from the damage 
caused by moisture, avoid direct contact with patient’s body, connect the MOSFET sensor 
by thin aluminum contact and provide 0.07 mm build-up layer of water equivalent depth. 
The dimensions of the MOSkin sensor are 0.8 x 0.6 x 0.35 mm3 with 0.55 µm thickness 
of gate oxide to provide a high spatial resolution of measurements (Kwan 2009). The 
MOSkin packaging dimensions are 10 x 1.8 x 0.45 mm3 (Figure 17). MOSkins  provide 
real time measurements with a negligible perturbation of the radiation field; it is possible 
to optimize its sensitivity and reproducibility by varying the silicon oxide thickness and 
varying the bias external voltage applied on the gate electrode (Jong et al., 2014).  
The MOSkin dosimeter system consists of MOSkin reader, MOSkin dosimeter and 
connected wires (Figure 18). The read-out process is achieved by measuring the voltage 
across the oxide gate, called the threshold voltage (Vth) and increment of the Vth is 
proportional to the absorbed dose.  
Many studies have reported the suitability and reliability of using the MOSkin dosimeter 
for real time in vivo skin dosimetry in different radiation therapy applications (Kwan et 
al. 2008; Jong et al. 2014; Al-Rahbi et al., 2018; Jamalludain et al., 2019; Qi et al.,2009; Kelly 









   
Figure 17. Schematics of a MOSkin dosimeter (a) MOSkin side view (b) MOSkin top 
view (Kwan 2009). 
 
 
Figure 18. MOSkin dosimeter system consists of MOSkin reader, MOSkin dosimeter and 







Chapter 3- Investigation into the MOSkin design, to improve 
its sensitivity and lifespan. 
 
This chapter presents a material published in Biasi et al., (2020) On the Combined Effect 
of Silicon Oxide Thickness and Boron Implantation Under the Gate in MOSFET 
Dosimeters. IEEE Transactions on Nuclear Science, 67(3), pp.534-540. The candidate 




In image guided radiation therapy, cone beam computed tomography (CBCT) uses either 
6 MV or kilovoltage photon beams. Historically, imaging dose has been ignored despite 
additional dose being delivered to organs (Alaei and Spezi, 2015). Recently, the MOSkin 
was used for dose monitoring in CBCT (Quinn et al., 2011) and in CT (Pereira et al., 
2019). Quinn et al. and Pereira et al. reported that the minimum detectable dose for the 
MOSkin was 0.401 cGy and 0.149 cGy in megavoltage photon beams and in x-ray tube 
operating at 150 kVp, respectively. 
This chapter describes investigations performed to study the related effects of SiO2 
thickness and boron implantation under the gate on the sensitivity and lifespan of a 
MOSFET device. The boron (B) implantation under the gate oxide was performed before 
growing the SiO2 layer. The basic MOSFET device was as described in the literature 
review (Chapter 2). The MOSFET has source, drain, gate (SiO2, the radiation sensitive 





During exposure to radiation, when an external positive bias applied to the gate of the 
MOSkin, its response (as in equation 3.1) is linear with absorbed dose (D) and the 





2 𝑓𝐸       ……  ( 3.1 ) 
Where the constant k1 is 
 k1 = 39 (
𝑚𝑉
𝑐𝐺𝑦 𝑢𝑚2
 )………..    (3.2) 
Equation (3.1) shows that MOSkin sensitivity can be modified either by making a SiO2 
of various thickness (tox) or changing the external bias applied during irradiation to act on 
the fractional yield (fE).  
3.2 Methodology 
 
In this study, various MOSkins  were considered, with a different thickness of the SiO2 
and a different amount of boron implantation under the gate. The thickness of SiO2 was 
either 0.68 µm or 1.0 µm and the amount of boron implantation under the gate was either 
0.0 (non-implanted), 0.2 or 0.6 µC/cm2. The MOSkin was primarily established for skin 
dosimetry in radiation therapy (Kwan et al., 2008). The MOSkin packaging was as 
described above and show in Figure 17 to be suitable for skin dosimetry. 
The MOSkin threshold voltage reader was correct to within ±1 mV; its voltage cut-off 
was 26 V; drain-source current was ~100 μA. The current was set at the thermostable 
point to reduce dependence on temperature (Buehler et al.1993) 
The linearity of the response as a function of absorbed dose was evaluated by irradiating 
the MOSkin in 6 MV photon beams delivered with a linac. MOSkins were positioned on 




at 100 cm a source-to-surface distance (SSD) and their top surface were aligned 
perpendicular to the central axis of the beam. In active mode, the external positive bias 
supplied was 15 V on the gate during irradiation and in biased mode, source, substrate 
and drain terminals were all grounded. To evaluate the MOSkin sensitivity in MV photon 
beams, the same experimental conditions were used as a function of absorbed dose. The 
limits of the voltages on a gate used were 15 and 150 V to evaluate the MOSkin sensitivity 
as a function of the external positive bias used on the gate during irradiation. 
Furthermore, X-ray tube voltages of 50, 75, 100 and 150 kVp were used to irradiate 
MOSkins in the photon beam.  MOSkins were positioned on top of 30 cm of solid water-
equivalent slabs, at 30 cm SSD and they were aligned with the central beam axis. The 
sensitivity was evaluated as a function of X-ray tube voltage when the external MOSkin 
bias was 15 V on the gate during irradiation; further, the device sensitivity was evaluated 
as a function of the bias on the gate for tube voltages of 50 kVp and 125 kVp. The means 
were reported as outcomes and the uncertainty were reported as two standard deviations. 
Each irradiation was repeated at least twice, and all values of absorbed dose are reported 
as dose to water. 
3.3 Results and discussion 
 
3.3.1 Decrease of the initial threshold voltage 
 
The initial threshold voltage for the MOSkins (Vth) is shown in Table 2. When other 
factors are kept equal and the thickness of the SiO2 layer(tox) is increased, the initial 
threshold voltage climbs higher. Back in 2014, Alshaikh et al. (Alshaikh et al., 2014) 
reported that the initial threshold voltage of a virgin MOSkin (SiO2 of 0.55 μm, non-




V for a non-implanted MOSkinTM with a 0.68 μm  thickness of SiO2 and used readout 
current.   
Table 2: MOSkin explored; each initial threshold voltage refers to the average calculated 
over three MOSkins with the same construction ± 2 standard deviations. 
 
In the study of Haran et al. (2005), increasing levels of B implantation was decreased the 
initial threshold voltage. In our study this outcome was confirmed. When the thickness of 
SiO2 was of 0.68 μm, the initial threshold voltage decreased by about 0.819 V between 
non-implanted MOSkins and those implanted with 0.2 μC/cm2 of B. The Vth then 
decreased by about 1.427 V between implanted levels of 0.2 μC/cm2 and those implanted 
with 0.6 μC/cm2. Also, when the thickness of SiO2 was increased to 1.00 μm, the initial 
threshold voltage decreased by about 1.349 V between MOSkins implanted with 0.2 
μC/cm2 B and those implanted with 0.6 μC/cm2. 
Whatever  the thickness of the SiO2, in our study there was a decreased of the initial 
threshold voltage of about 4.1 V for each 1 μC/cm2 of B implantation in the limit from 
0.0 and 0.2 μC/cm2.  Next, the decrease was of about 3.5 V for each 1 μC/cm2 of 
implantation when changing the B concentration from 0.2 to 0.6 μC/cm2. 
 3.3.2 Response linearity as a function of absorbed dose 
 
The relationship between MOSkins response and the absorbed dose was linear (Figure 
19).  




3 0.68 0 12.362±0.166
6 0.68 0.2 11.543±0.242
7 0.68 0.6 10.116±0.180
11 1 0.2 16.273±0.455





Figure 19: MOSkins response linearity as a function of absorbed dose; external bias during 
irradiation was 15 V. (3,6,7,11 and 14 refers to MOSkins as in Table 2) 
 
The response was linear in the range from 0 to 4400 cGy and from 0 to 1500 cGy for non-
implanted MOSkins with a SiO2 thickness of 0.68 μm or  1.00 μm, respectively. That 
range was from 0 to 5000 cGy and from 0 to 1700 cGy for implanted MOSkins with a 
SiO2 of 0.68 μm and of 1.00 μm, respectively. The MOSkins with the 1.00 μm thickness 
of SiO2 had a shorter range because of their higher sensitivity (the linear dynamic range 
was limited by the reader voltage cut-off of 26 V was reached at a smaller absorbed dose 
level).   
 
3.3.3 Sensitivity as a function of photon energy 
 
Jong et al. (2017) used 6 MV photon beams (effective photon energy of about 1 MeV) 
and reported that the sensitivity of a MOSkin with 0.55 μm thickness of SiO2 (no boron 




In this study, when the SiO2 thickness was increased, sensitivity increased (Figure 20, 
Table 3).  
Table 3: Initial sensitivity (S) of virgin MOSkins in Megavoltage photon beams. Similarly, 
sensitivity averaged (Ŝ) over the whole range of linearity; its spread/error is measured as 2 
standard deviations. 
 
         
By using equation (3.1), measured sensitivities can be compared to calculated sensitivities 
for 0.55 μm thickness of SiO2 and, as a first estimate, using the values of the constant k1 
and of fractional yield (fE),   as approximately independent of the thickness of the SiO2. 
The calculated sensitivity for 0.68 μm thickness of SiO2 was 3.807 mV/cGy (vs. a 
measured value in the limit from 3.130 to 3.352 mV/cGy, Table 3); that for SiO2 of 1.00 
μm thickness was 8.233 mV/cGy (vs. a measured value in the limit from 6.818 to 7.008 
mV/cGy, Table 3). 




0.68 0 3.443±0.031 3.266±0.236
0.68 0.2 3.483±0.042 3.352±0.030
0.68 0.6 3.383±0.042 3.130±0.463
1 0.2 7.073±0.101 7.008±0.143





Figure 20: MOSkin Sensitivity as a function of absorbed dose in megavoltage photon beams: 
external bias during irradiation was a constant 15 V (3, 6, 7, 11, 14 refer to MOSkins in table 2).  
 
Changes between calculated and measured values are clarified by the dependence of the 
constant k1, and of the fractional yield, on the thickness of the SiO2; in thicker SiO2 there 
is a smaller electric field (in units V/μm), the recombination process is more effective, 
and the fractional yield is smaller (Schwank et al., 2008 and Shaneyfelt et al., 1991).  
MOSkins in high-energy photon beams were only irradiated by energies up to 6 MV  
because in the megavoltage photon limit (up to   ̴ 25 MV), MOSkin sensitivity is constant 
(Ramani et al. 1997; Ramaseshan et al. 2004 & Halvorsen 2005). 
When exposed to low-energy X-ray photons (“soft x-rays”) from 10 keV to 200 keV, 
MOSkins are supposed to have reach a sensitivity limit which ( normalized to its 
sensitivity in high-energy photons of a few MeV) is bigger by a factor of 3 to 4. At photon 




Kron et al., 1998) that determined photo effect cross section energy dependence and 
MOSFET packaging. 
Pereira et al. (2019) reported that the sensitivity of a MOSkin when photon beams were 
produced with x-ray tubes running at 100 kVp, 120 kVp and 150 kVp was 9.21 mV/cGy, 
7.69 mV/cGy and 6.72 mV/cGy, respectively for the gate bias 15 V. Sensitivity reduced 
as a function of x-ray tube voltage, in addition, sensitivity at 100 kVp was about 3.7 times 
that in 6 MV photon beams under the same gate bias 15 V during irradiation.  
In our study, we confirmed those trends in MOSkin sensitivities (Figure 21, Table 4); 
specifically, sensitivity at 100 kVp was about 5 times that in 6 MV photon beams, when 
comparing devices with the same thickness of SiO2 and level of  B implantation.  
Table 4: Initial sensitivity (S) of virgin MOSFETs in 50 kVp and in 100 kVp photon beams 
 




0.68 0 22.100±1.131 18.200±0.346
0.68 0.2 21.567±0.808 19.100±1.311
0.68 0.6 20.433±1.007 18.100±1.400
1 0.2 38.067±0.945 38.033±2.579





Figure 21: MOSkin sensitivity as a function of orthovoltage x-ray tube running voltage. External 
bias during irradiation was kept constant at 15 V throughout (3, 6, 7, 11 and 14 refers to MOSkins 
in table 2).  
 
In Haran et al. study (Haran et al., 2005), boron implanted MOSkins had a higher 
sensitivity than non-implanted ones. That outcome was clarified in terms of further 
defects being generated in the SiO2 because of boron being implanted during the SiO2 
formation through the gate oxide. In this study, implantation was achieved before 
increasing the SiO2 thickness to nominal value. That sensitivity did not alter as a function 
of  boron implantation concentration; instead, sensitivity was determined by the thickness 






3.3.4 Sensitivity as a function of external bias 
 
Figure 22 and Figure 23 display the relationship between sensitivity and external bias 
used on the gate during irradiation (Vg). In both megavoltage and kilovoltage photon 
beams, when positive external bias was increased, MOSkin sensitivity also increased. 
In megavoltage beams, the highest bias needed for operation was about 90 V for MOSkins 
with a 0.68 μm thickness of SiO2 . The corresponding value was about 120 V for MOSkins 
with a SiO2 thickness of 1.00 μm where the saturation produces a full charge collection. 
In kilovoltage beams, the highest bias used (90 V) did not produce a full charge collection 
in any of the MOSkins. Those outcomes are clarified by taking into consideration the 
fractional yield as a function of the electric field in the SiO2. When the photon irradiation 
beam energy is kept equal, the thicker the SiO2 , the greater the positive external bias 
needed to create the same electric field and, in consequence, to saturate the fractional 
yield. Alternatively, when thickness of the SiO2 layer is kept equal, a denser electron-hole 
pair plasma is created by low-energy photons. To saturate the fractional yield a stronger 






Figure 22: MOSkin sensitivity as a function of positive external bias used on the gate during 






Figure 23: MOSkin sensitivity as a function of positive external bias used on the gate during 
irradiation.  Irradiation was in beams formed with orthovoltage x-ray tubes operating at voltages 
of (a, b) 50 kVp and (c, d) 125 kVp (3, 6, 7, 11 and 14 refers to MOSkins in table 2).  
 
3.3.5 Instability of the threshold voltage 
 
In a prior study from Haran et al. (Haran et al., 2005), B implantation reduced the 
instability of the threshold voltage each time the MOSFETs were used with an external 
bias. Similarly, MOSFETs with a 1.00 μm thickness of SiO2 yielded measurements with 
less variability than MOSFETs with a 0.40 μm thickness of SiO2 . This was, probably, a 
consequence of the poorer reproducibility of the thicker SiO2 gate oxide. 
In this study, B implantation had no influence on the instability of the threshold voltage 
in MOSkins used under external bias. Instead, the instability of the threshold voltage was 




Figure 23). MOSkins with a 0.68 μm thickness of SiO2 yielded measurements which had, 
on average, a reproducibility 1% better than those with a 1.00 μm thickness of SiO2, 
whatever the B implantation; reproducibility worsened when the external bias was 
increased above 80 V. 
3.4 Conclusion 
 
This study explored the related effect of the thickness of the SiO2 layer and the level of 
boron implantation in MOSkinTM dosimeters. The thicknesses of SiO2 that were used in 
this study were either 0.68 μm or 1.0 μm while boron implantation level was either 0.0 
(non-implantation), 0.2 or 0.6 μC/cm2.  
 The main outcomes of this study are that MOSkins with a thicker SiO2 had an improved 
sensitivity under the same gate bias during irradiation. However, increasing of initial 
threshold voltage, is leading to reduction  of lifespan (for a given read-out system max 
measured Vth 27V). No essential sensitivity degradation (linearity of the response) within 
lifespan that can be expanded with increasing of maximum readout Vth by the reader. 
Boron implantation under the gate before growing the gate oxide SiO2 has technological 
advantage. MOSkin sensitivity did not change as a function of boron dose implantation. 
The boron implantation did not boost instability of the threshold voltage in MOSkins used 
under positive gate external bias investigation in this work. The most important features 
of our MOSkin fabrication technology that boron implantation is essentially reducing 
initial Vth (i.e. increasing lifespan of the MOSkin) and spread-out of initial sensitivity is 
less than 1%. Last feature is very important as allow prescribe the same sensitivity to the 




Chapter 4 - eXaSkin: a novel high-density bolus for 6 MV X-
ray radiation therapy 
 
This chapter, is based on material published in Al-Sudani et al. (2019) “Dose build up 
characteristics with eXaSkin bolus during 6MV radiotherapy: MOSkin dosimetry results.” 
In Journal of Physics: Conference Series (Vol. 1154, No. 1, p. 012024). IOP Publishing., and Al-
Sudani et al. (2020) “eXaSkin: A novel high-density bolus for 6MV X-rays radiotherapy”. Physica 
Medica, 80, pp.42-46. These reports discuss the experimental investigations results to evaluate 




In external radiation therapy, calculation of surface and build-up dose is an important issue to 
avoid recurrence of a near surface tumour or skin toxicity. The dose at the skin is lower than the 
maximum dose by about 25% because of the skin sparing effect (Quach et al. 2000). Head and 
neck cancers present many challenges in radiation therapy because of they exist near many critical 
structures and there is an irregular contour of this region and planning volumes may need to be 
expanded if there is any tumours near surface (Hsu et al., 2008, Luu et al., 2015).  
The main factors affecting calculations of surface dose are the beam geometry of incident beams, 
electron contamination from the head of the Linac and bolus material (Metcalfe et al., 2012). The 
accuracy of dose calculation at surface with a treatment planning system (TPS) is within 20% 
(Jong et al., 2016, Fraass et al., 1998, Court et al., 2008, Panettieri et al., 2009, Chakarova et al., 
2012, Akino et al., 2013, Chung et al., 2005).  
Boluses are used in radiation therapy to provide a build-up region near the skin, compensate for 
irregular surfaces, reduce the depth of maximum dose (dmax) and increase the dose to the surface 
depending on the bolus material density (Luu et al., 2015 and Alexander et al., 2019). For 
example, the Superflab bolus is commercially used in radiation therapy. It is a synthetic oil gel 
based on a vinyl polymer with di-isodecyl phthalate and physical density 1.02 g/cm3. Superflab 




when used on irregular surfaces. Yoon et al. (2018) found that the surface dose when using a 6MV 
open X-ray field (2000 MUs) without bolus was 51.5±0.8 cGy, whereas with a 1 cm Superflab 
bolus 139.3±2.9 cGy surface dose was produced. However, it is often difficult to achieve perfect 
contact and conformity with a patient’s skin resulting in air gaps on irregular surfaces causing a 
reduction of up to 10% in the surface dose for air gaps larger than 10 mm for 6MV in radiation 
fields less than 10x10 cm2 size (Khan et al., 2013, Manger et al., 2016). Given the need for 
conformity, the radiation oncologist may seek a more suitable material.  
Recently, brass mesh (Manger et al., 2016, Al-Rahbi et al., 2018) was introduced as an alternative 
high density bolus to the Superflab bolus. The studies state that the surface dose obtained with 
this brass mesh bolus (density = 8.73 g/cm3) were similar to or slightly less than the dose obtained 
with a Superflab bolus. The brass mesh bolus with 2 mm thickness does not affect significantly 
on depth dose < 0.5%. However, Manger et al reported that brass mesh bolus may be used with 
high energy photons (15 MV, 24 MV) but with potential produced photoneutron effective dose to 
staff and patients.   
This chapter investigated the effect of a novel high-density bolus eXaSkin (manufactured by 
Anatomical Geometry, Spain) on skin dose, as an alternative to SuperflabTM bolus. The dose in 
the central target volume was studied for head and neck cancer treatment using dual arc VMAT.   
4.2 Methodology 
 
4.2.1 The preliminary method 
 
This method was involved calculating the density by measuring the weight and the dimensions of 
eXaSkin slabs. It was investigated the dose in the build-up region and the effect of oblique 
incident angles for eXaSkin slabs and solid water slabs. 
4.2.1.1 Build-up region dose measurements 
 
The eXaSkin bolus (AnatGe, Spain) is a new material (figure 24), which is composed of two 
components.  Combining the two basic components of eXaSkin produces a new material, which 
harden in about two minutes. For build-up measurements, eXaSkin bolus were cuts into 10 x 8 




calculated by measuring its slabs dimensions and their weights. The build-up region of eXaSkin 
at depths (0, 3, 5, 8, 10, 15 and 26 mm) was compared with the build-up of solid water equivalent 
slabs (Gammex, model 457, USA) (Figure 25) at depths (0, 2, 5, 15, 20 and 26 mm) by using an 
advanced Markus chamber and MOSkin dosimeters. The advanced Markus chamber dosimeter 
was placed inside a groove in a 2 cm solid water equivalent slab and the MOSkin was placed in a 
groove in 0.5 cm solid water slab. PDDs were performed with a 6MV Varian Clinac iX (Varian 
Medical Systems, Palo Alto, CA) at the ICCC in Wollongong- Australia for irradiated field sizes 
of 5 x 5 cm2 and 10 x 10 cm2, with 100 MU doses at 100 cm SSD with 10 cm solid water equivalent 
slabs as backscatter material. All the measurements were normalized to dmax and repeated three 
times. Rawlinson’s (1992) over-response correction formula for the advanced Markus ionization 
chamber was used as in equations 2.1 to 2.3. 
                                                 
 
 
Figure 24: eXaSkin material added on top of a solid water-equivalent slab patient “phantom”. 
                       
                   
 
                                    




                                                                                   
4.2.1.2 Effect of Oblique incident beam on the surface 
 
The percentage surface doses (PSD) for different incident angles were measured at the surface 
without any bolus and at 3 mm into eXaSkin and solid water-equivalent slabs by using an 
advanced Markus chamber and MOSkin  dosimeter.  The oblique incidence beam was investigated 
at 0 º, 15 º, 30 º, 45 º, 60 ºand 75º beam angles for 6 MV 100MU photon beams, 100 SSD and 
10x10 cm2 field size. All the measurements were normalized to dmax and repeated three times. 
4.2.2 The advanced method 
 
In this method, CT scans were used to calculate the density of the eXaSkin bolus. A STEEV 
phantom was used to measure the skin dose when using the VMAT technique. 
 4.2.2.1 Set-up of bolus materials and planning 
 
A commercial anthropomorphic phantom was used for the study, the Stereotactic End-to-End 
Verification Phantom (STEEV; CIRS) (Figure 26). STEEV mimics significant internal anatomy 
in the head-and-neck region, such as cortical and trabecular bones, spinal cord, teeth, sinuses, and 
trachea.  
                                                                
 
 
            Figure 26: STEEV phantom. It is composed of three parts with a central cubic volume. 
 




cm uniform thickness piece of commercial Superflab (Med-Tec). Bolus, the second- an eXaSkin 
- high-density bolus with adjustable thickness. The eXaSkin was spread onto the side of STEEV 







Figure 27: Left panel: STEEV with SuperflabTM bolus. Right panel: STEEV with eXaSkin bolus.  
 
STEEV was imaged with a Siemens Somatom 64 slice computed tomography (CT) scanner, using 
a clinical head and neck protocol with slice thickness of 2 mm each. Scans of the phantom were 
performed for three different scenarios: no bolus, Superflab, and eXaSkin. CT images (Figure 28, 
29) were transferred to a commercial treatment planning system (TPS), a Pinnacle3 v14; (Philips 
Medical Systems); wherein a collapsed cone convolution algorithm was used for dose 
calculations. On the CT data set, PTVs were contoured to a central target in the nasopharynx 
region, and to a second more superficial region representing neck lymph nodes (Figure 30). 
Surrounding organs at risk were also delineated to replicate typically head and neck anatomy. 
Planning was performed for using a volumetric modulated arc therapy (VMAT) technique; with 
dual coplanar clockwise/counterclockwise arcs, delivered with 6 MV photon flattened beams 
produced with a TrueBeam (Varian Medical Systems) medical linear accelerator (linac). A 
radiation dose of 70 Gy in 35 fractions was prescribed to the 100% isodose line. 2 Gy per fraction 
was delivered to the central target, and 1.8 Gy per fraction was delivered to the lymph node region. 
In addition to VMAT, a simple 10x10 cm2 open field at 90° also was applied to verify that the 
TPS accurately models the dose downstream of the bolus using a basic beam set-up. This was 









Figure 28: Left panel: slice of imported CT scan of STEEV with Superflab bolus on exterior 
left face surface. Right panel: slice of imported CT scan of STEEV with eXaSkin. In each 
picture, the central circle with “IC” tag indicates ionization chamber location; the labels 






Figure 29: Left panel: coronal slice of imported CT scan of STEEV with Superflab. Right panel: 
coronal slice of imported CT scan of STEEV with eXaSkin. In each picture, the central circle 
with “IC” label indicates ionization chamber location; to the right, the labels “MOSKIN1” 








                                  
Figure 30: Left panel: slice of imported CT scan of STEEV with SuperflabTM and the PTV 
contoured to a central target in the nasopharynx region. Right panel: slice of imported CT scan 
of STEEV with SuperflabTM and PTV were contoured to superficial region representing a neck 
lymph node. 
 
4.2.2.2 Measurements  
Doses were measured in the central planning target volume (PTV) in the nasopharynx region to 
verify TPS modelling at depth, and at the “surface” (immediately under the bolus) to verify dose 
calculations in the build-up region. Measurements were performed in each of the three scenarios 
(i.e. no bolus, Superflab, eXaSkin), both for the VMAT plan and for the static field. 
To measure dose in the central target, we positioned a CC13 ionization chamber (TNC/5597; IBA 
Dosimetry) inside STEEV in a dedicated chamber cavity. The ionization chamber had been 
previously calibrated under reference conditions to determine an average charge to dose 
sensitivity of 26.46 nC/cGy. 
To measure surface dose, we placed a MOSkin at each one of the three lymph node sites in the 
treated region. The MOSkin is a semiconductor dosimeter developed at the Centre for Medical 
Radiation Physics (University of Wollongong, Australia) for measurements of skin dose in 
modern radiotherapy (Jamalludin et al., 2019 and Jamalludin et al.,2019); its packaging provides 
a highly reproducible water-equivalent depth (WED) of measurement of 0.07 mm, as 




calibrated at a depth of 1.5 cm, 100 cm source-to-surface distance (SSD), in a solid water 
phantom (model 457; Gammex). Irradiations were performed in 10 × 10 cm2 fields produced with 
6 MV flattened beams. The calibration factor (CF) was calculated via CF = ∆V/D, where ∆V is 
the average threshold voltage shift (in unit mV), and D is the delivered dose (in unit cGy). The 
CF of the three MOSkin dosimeters with oxide gate thickness 0.55 µm was 2.24 ± 0.02 mV/cGy. 
Before applying the bolus, each MOSkin was placed at locations identified by CT markers on the 
left side of STEEV (MOSkin #1, #3), and at 2 cm from MOSkin #1 (MOSkin #2).   
4.3 Results 
 
4.3.1 The preliminary method 
 
4.3.1.1 Build-up region dose measurements 
  
The density of eXaSkin was 1.7 ± 0.03 g/cm3 compared with 1.04 g/cm3 for PMMA used in solid 
“water-equivalent “phantoms. For the eXaSkin and the solid water-equivalent slabs, Figure 31 
show PDD measurement with an advanced Markus chamber and Figure 32 show PDD 
measurement with MOSkins, for field sizes of 5 x 5 cm2 and 10 x 10 cm2. The PDD of eXaSkin 
for both field sizes was higher than the PDD of solid water in the range 2-10 mm where both were 
normalized to dmax. 
 






                                                                         (b) 
 
Figure 31: Build-up region for solid water-equivalent slabs vs eXaSkin slabs measured with an 
advanced Markus ionization chamber in (a) 5 x 5 and (b) 10 x 10 cm2 fields at depths in the range 
of 0-26 mm. 
 






                                                                    (b) 
 
Figure 32: Build up region for solid water-equivalent slabs vs eXaSkin slabs measured with 
MOSkins in (a) 5 x 5 and (b) 10 x 10 cm2 fields at depths in range 0-26 mm. 
 
 The dmax of solid water was at 15 mm depth (for bolus of density 1.04 g/ cm
3) compared with an 
eXaSkin density dmax of 9 mm (1.7 g/ cm
3). 
The comparison of the PDD of eXaSkin measured by an advanced Markus ionization chamber 
measurement and MOSkin dosimeters for both field sizes (5 x 5 and 10 x 10 cm2 see Figure 33) 
shows that the large difference between the 2 types of dosimeter is at 0 mm for both field sizes 
(7% higher readings from MOSkin dosimeters than ionization chamber readings). This is 
attributed to the different in water equivalent depth of measurement (WED of MOSkins being 






                                                                      (a) 
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Figure 33: PDD of eXaSkin as reported by an advanced Markus ionization chamber and MOSkins 
for (a) 5 x 5 cm2 and (b) 10 x 10 cm2 radiation fields. 
 
4.3.1.2 Effect of Oblique incident beam on the patient phantom surface 
 
Figure 34a demonstrates the changes of the percentage surface dose with oblique incident beams 
of 6 MV, 100 SSD and 10 x 10 cm2 field size. Advanced Markus measurements and MOSkins 
were used. The percentage surface dose increases when the incident beam angle increases because 
the charged particle equilibrium CPE shifts near the surface in agreement with the Jong (Jong, 




at all angles as shown in Figure 34c and can be compared with the percentage dose at 3 mm depth 
in a solid water-equivalent slab (Figure 34b) and at the surface (Figure 34a). The largest difference 
in measurements between the advanced Markus chamber and a MOSkinTM dosimeter with 3 mm 
eXaSkin was -11% at 75º, attributed to the eXaSkin bolus not covering the entire irradiated 
surface (the eXaSkin slab dimensions were 10 x 8 cm2 as noted in Figure 24, but the irradiating 
beam is 10 x 10 cm2). There may also be a small effect due to the size and the structure of each 
dosimeter.  
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Figure 34. The percentage dose for the oblique incident beam by using the advanced Markus 
chamber and the MOSkins (a) at the beam entry surface (b) at 3mm depth in Perspx and (c) at 
3mm depth in eXaSkin. 
4.3.2 The advanced method 
 
The density and thickness of eXaSkin was taken from CT images. Density was estimated to be 
1.59 g/cm3, whereas the layer thickness varied between 1.1 cm, 1.0 cm, and 1.2 cm at the position 
of MOSkin #1, #2 and #3, respectively. In contrast to Superflab case, there were no air gaps 
between the surface of STEEV and the eXaSkin (Figure 28, Figure 29). 
In the case of the static field of 10 x 10 cm2, the dose at the central target, as measured with CC13 
and as calculated with the TPS, is as shown in Table 5. The measurements in Table 5 are basic 
raw results assuming that the TPS is calculating the dose accurately through each type of bolus 
and that the radiation transport through the higher density material of the eXaSkin is well 
modelled by the TPS. The no bolus ionization chamber measurement provided the reference 
scenario, and it can be observed that the results in all three scenarios are almost the same. Dose 
to the skin, which is reported in Table 5, was measured with MOSkin #1 and #2 only (MOSkin 
#3 was placed outside the 10 x 10 cm2 radiation field and was ignored). The MOSkin 




bolus materials. In addition, the large difference between measured and TPS reported doses in the 
“no bolus” case highlights the inaccuracy of the TPS for calculating dose at the surface of the 
skin. 
Table 5: Measurements and calculations in 10 x 10 cm2 a static field. Dose at the central target 
measured with ionization chamber in three different scenarios: no bolus, Superflab, eXaSkin. Skin 





For VMAT plans, dose at the central target, as measured with CC13 was compared to the dose 
calculated with the TPS at a point corresponding to the central axis of the ionization chamber 














MOSkin  #1 116.03±1.30
TPS 115.7
% difference 0.28


















Table 6: VMAT plan measurements and calculations. Dose at the central target in three different 
scenarios: no bolus, Superflab, eXaSkin. Skin dose at lymph node site #1, #2 and site #3 in three 
different scenarios: no bolus, Superflab, eXaSkin. 
 
In all scenarios, the measurements with MOSkin and CC13 were repeated three times.  As can be 
observed in Table 6, there is a high standard error (4%) with MOSkin#3 and Superflab bolus 
during the VMAT plan. The standard error For CC13 is zero. 
4.4 Discussion 
 
Skin dose assessment with an eXaSkin bolus is essential to ensure dose delivery to near- surface 
tumors without producing excessive skin reaction. According to the manufacturer, eXaSkin has a 
density of 1.53 g/cm3. In the classic method, the density of eXaSkin material was calculated by 
measuring its slab’s dimensions and their weights was 1.7± 0.03 g/cm3. In the advanced method, 
the density based on CT-scanned images was estimated to be 1.59 g/cm3. This is consistent with 
that stated by the manufacturer (1.53 g/cm3), within +/-3.4%.  
In the classic method, the eXaSkin bolus delivered high dose at depth 2-10 mm and a high dose 
to the skin at high angles in range 0°-75° compared with the plain solid water-equivalent slab 
phantom. 
No bolus Superflab eXaSkin
CC13 201.4 202.2 197
TPS 202.8 201.4 198.8
% difference -0.7 0.4 -0.9
MOSkin  #1 32.21±0.00 61.76±1.98 70.81±2.50
TPS 32.59 55.31 69.51
% difference -1.17 11.66 1.87
MOSkin  #2 41.05±1.98 63.16±0.00 76.24±0.00
TPS 39.94 59.51 74.05
% difference 2.78 6.13 2.96
MOSkin #3 116.19±0.32 166.12±4.00 167.91±1.98
TPS 116.22 161.34 158.88






In the advanced method, the eXaSkin demonstrated superior adaptation to the skin surface, 
producing minimal air gaps, allowing for accurate positioning and reproducibility of set-up 
conditions. On CT images, some small air bubbles are observed inside the eXaSkin bolus (see 
Figure 29 right panel); this can be prevented by more firmly pressing the bolus material, which is 
flexible. Also, the layer of eXaSkin was observed to be slightly non-uniform: its thickness varied 
in the range from 1.0 cm and 1.2 cm, as measured at the position of each MOSkin. However, if 
eXaSkin is placed before acquiring the planning CT image, its exact density, shape and thickness 
can be taken into account by the TPS using the CT data. 
Dose was first assessed at the central target and at the surface using a 6 MV static field of 10.0 x 
10.0 cm2. In all scenarios (no bolus, Superflab, eXaSkin), dose at the central target, as measured 
by CC13, was slightly higher than that calculated by the TPS, but agreeing to within 1.6%. Skin 
dose measured at the lymph node sites #1 and #2 showed differences with TPS calculations as 
large as 28% when no bolus was used. This significant variation was expected, because the TPS 
is known to be generally less accurate (within 20%) in the build‐up region (Fraass et al., 1998, 
Court et al., 2008, Panettieri et al., 2009, Akino et al., 2012 and Chakarova et al., 2012). With the 
added build-up provided by bolus, measurement and calculations of skin dose agreed to within 
1.22%.  
In our second round of measurements, we assessed dose at the central target and at the surface 
during VMAT delivery. In all scenarios, dose measured at the central target and calculations with 
the TPS agreed to within 1%. Skin dose at lymph node sites #1 to #3 was higher when bolus was 
used, as expected because of added build-up. A notable observation was that, in the VMAT 
delivery, the measured skin dose had a better agreement with calculations in the “no bolus” 
scenario. This can be explained by considering that, during arc deliveries, a more significant 
portion of the dose to the skin is scattered within the phantom and a less significant portion is 
produced by build-up.  
For the VMAT plan, MOSkin results for the VMAT plans showed agreement with the TPS 
underneath the eXaSkin to between 2-6%. The dose at the skin underneath the Superflab showed 




reproducing the position of the bolus from CT imaging to linac measurement. The consequence 
of larger air gaps on the surface depends on multiple parameters (beam energy, radiation field 
size, and angle of incidence). An air gap of 1 cm between Superflab and skin produced a 
significant error, but this became insignificant for fields of 10 × 10 cm2 or larger (Khan et al., 
2013). Errors become more important with increasing adoption of highly conformal techniques, 
which use small field apertures and multiple beams from different angles.  
4.5 Conclusions 
 
 In this chapter, eXaSkin, a novel high-density bolus for megavoltage radiotherapy, was shown to 
have many favorable characteristics over the Superflab bolus such as: superior adaptation to the 
skin surface, producing minimal air gaps or bubbles, allowing for accurate positioning and 
reproducibility of set-up conditions. Measurement of dose underneath the bolus showed good 
agreement with the TPS calculations, indicating the higher density material was accurately 
modelled within the TPS. Overall, we conclude that the eXaSkin bolus is a viable option to treat 


























Part 2 – The Octa dosimeter 
 
 
The Octa is a 2D monolithic silicon array dosimeter. It was designed at the CMRP at 
University of Wollongong, Australia. The Octa based on a high resistivity p-silicon 
substrate epitaxial grown on top of a low resistivity p+ substrate. It has 512 strip-SVs 
spread out along four intersecting orthogonal linear arrays oriented 45° with respect to 
each other. All the SVs have the same area of 0.032 mm2 with a rectangular shape 
dimensions of 0.04 mm wide and 0.80 mm length except the nine central pixels which 
have dimensions of 0.16 mm wide and 0.20 mm length. The total dimensions of the Octa 
is a 38.7 mm wide and 38.7 mm length with 0.3 mm pitch for vertical and horizontal 
arrays and 0.43 mm pitch for diagonal arrays (Figure 35a). Furthermore, adding a small 
air gap on top of the SVs to maintain correction factors close to unity. The Octa is covered 
by an epoxy resin with a 0.10 mm thickness to protect it against moisture and accidental 
damage. The Octa is placed between two Perspex plates with a 5 mm thickness each 
(Figure 35 b). It is wire bonded to a 0.5 mm thick of printed circuit board (PCB) for 
connection to a multichannel read-out data acquisition (DAQ) system (Figure 35c). The 
DAQ is based on a field- programmable gate array (FPGA) Xilinx Spartan 3, four 
analogue to digital converters (ADC) and eight analogue front-end (AFE) AFE0064 
(Texas Instruments) chips (Biasi 2019). The Octa is operated in passive mode (no bias 
voltage applied) and connected to DAQ. The epitaxial Octa is describing as the epitaxial 
layer is doped by adding a gaseous boron compounds to the environment leads to boron 
diffuses into the layer 
The Octa graphical user interface (GUI) software is used for real time visualization. When 
the FPGA connects to the PC, the GUI is turn on and the user can load the firmware in 
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Figure 35: The Octa dosimeter system. (a) The four arrays of the Octa (b) The Octa dosimeter 
between two plates (c) The Octa Data acquisition system (DAQ) (Biasi 2019) consists of 1-four 
boards (from left) with 2 AFEAs each 2- plastic case containing the FPGA and associated 
circuits with three ports for: i) USB link for data transmission to or from PC. ii) the power 
supply. iii) the coaxial cable for linac trigger signal acquisition. 
             
                    
 




Chapter 5 – Design of a custom-made phantom for using the 
Octa to ensure the quality of stereotactic body radiation 
therapy for vertebral metastases 
 
This chapter presents a custom-made phantom for using the Octa to ensure the quality of 
stereotactic body radiation therapy (SBRT) for vertebral metastases. The phantom was 
designed so that the Octa array can be set in a position parallel to the incident radiation 
beam, to measure dose distributions in a horizontal plane (Figure 37). The goal of SBRT 
for vertebral metastases is to deliver a high dose to the tumour in the vertebral bones, 
using small radiation beams, while sparing the spinal cord. 
 
   
Figure 37. Illustration and naming of the main human anatomical planes (top, a, b, c) and views 
of the human L3 vertebra (bottom images a, b, c) from a viewpoint normal to the same three 
anatomical planes respectively (Busscher et al., 2010). The position of the dosimeter to integrate 
into the phantom is centred on the L3 (lumber) vertebra and parallel with or in the horizontal 






Quality assurance (QA) procedures are essential for reducing the risk of errors in radiation 
therapy. QA includes pre-treatment verification of patient plans, to ensure the delivered 
dose in the relevant plan matches the dose calculated by the treatment planning system 
(TPS). Low et al (Low et al., 2010) introduced different dosimetric QA techniques to 
verify plans. A method for QA is to compare between calculated and measured doses 
using indirect dose verification with a patient specific dosimetric phantom (Oh et al., 
2017). 
SBRT for vertebral metastases delivers high dose to a small target area, using small 
radiation beams, with steep dose gradients in the delivered dose distribution. Hence, the 
QA necessitates an accurate dosimeter for small fields (Kim et al., 2017). 
Recently, to verify dose distributions in radiation therapy, various types of 3D printing 
technologies are used to manufacture spine phantoms (Oh et al., 2017, Kim et al., 2017, 
Tino et al., 2019) and various types of monolithic silicon array dosimeters have been 
manufactured with small sensitive volumes and sub-millimeter pitch, used for 2D dose 
mapping in small radiation fields (Biasi et al., 2019)  
The aim of this chapter is to describe the custom-made design of a phantom designed to 




In the present study, we report the manufacturing procedures for the phantom via the 
assistance of computer-aided design (CAD) technology (version 2014, Autodesk Inc.). 
The phantom was fabricated from poly-methyl-methacrylate (PMMA) with an arch 




separate plates (Figure 38a), a  front plate (Figure 38b), and a back plate (Figure 39). The 
front plate contains the air gap which protects the Octa and optimizes its response for 
small fields (Stansook et al.,2017). Figure 40 illustrates the dimensions of the print circuit 
board of the Octa to lodged it between the spine plates. 
  
              
                 
    
 
Figure 38. Side view of the PMMA spine phantom showing thickness dimension when using two 
component planes (100.50 mm) and when using only the front plane (50.50 mm), both 
configurations including the base of the phantom. 
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Figure 39. Back view for the PMMA spine phantom for the back plane (1) shows the width of the 
whole back plane (216mm) (2) shows the distance from the top to the center of the air gap in the 
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Figure 40. The dimensions of the printed circuit board (PCB) of the Octa, which is sandwiched 
between the front plane and the back plane of the spine phantom according to the air gap. (a) 
the distance from the top of the phantom to the center of the air gap of the phantom is 123 mm. 
(b) the width of the Octa PCB is 173 mm (c) the distance from the top of the rectangular shape 
to the center of the air gap.  
5.3 Results and discussion 
 
Vertebral metastases are tumours developing within the bones of the spine (Tseng et al., 
2017). Radiation therapy is the most common method to successfully treat these tumours 
through a modality such as SBRT (Lee et al., 2019). For QA in this context, a custom- 
made phantom of  PMMA was manufactured. This allowed for fulfilling the requirements 
for suitable QA of treatment plans by allowing measurement of the absorbed dose  and  
dose distribution penumbra (Chung et al., 2018).  
The custom-made phantom was constructed from two plates in an arch shape. The Octa 
can be located inside the phantom. The thickness of both plate is 100.50 mm which is 
50.5 mm for the front plate with an air gap.   
SBRT for vertebral metastases delivers high dose to the target and use a small radiation 
fields with a steep dose gradient at the edges of the dose distribution to avoid the spinal 
cord itself with the delivered dose distribution (Kim et al., 2017) (Figure 41). The 
common method to QA the treatment is to measure the dose distribution in the relevant 
treatment area, most commonly using a dosimeter in the frontal (coronal) plane or sagittal 
plane (Figure 37), but what we need is to measure the dose distribution in the transverse 
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      Figure 41. Isodose distribution of three-dimensional conformal radiotherapy for vertebral 
metastasis in different planes:  a) frontal plane b) sagittal plane c) horizontal plane (Lee et al., 
2019). 
 
 The Octa in the custom-made phantom can be used to measure the delivered dose 
distribution in the horizontal plan of the “tumour” region (Figure 42, Figure 43). The Octa 
dimension are 38.7 x 38.7 mm and the diameter of the spinal cord region is 10-15 mm. 
Hence, the Octa can measure the dose to the spinal cord and to an appreciable extent of 
surrounding area containing the tumour.  
 









A custom-made phantom for the Octa, with the aim of applications for quality assurance 














Chapter 6 - The angular dependence of the OCTA in a 





Recently, 2-D monolithic silicon array dosimeters have been used to ensure the quality of 
radiation therapy. One of the limitations of these dosimeters is that their sensitivity varies 
as a function beams of radiation beams’ angle of incidence. This is important when the 
dosimeter is used for measurements during arc deliveries, for instance VMAT, as the linac 
gantry rotates during delivery. 
 The angularly dependent sensitivity of a monolithic silicon array depends on the 
materials of the dosimeter sensitive volume (SV) as well as on the materials and volume 
of their packaging (Stansook et al., 2017). All these components perturb, to various 
degree, the secondary electron spectrum as a function of radiation’s incident angle. 
In this chapter, the angularly dependent sensitivity of the Octa inside a cylindrical 
phantom of solid water was investigated according to a procedure detailed by Stansook 




To study the angularly dependent sensitivity of the Octa, the Octa was inserted into the 
DosePoint (DosePoint GmBH, Wiesloch, Germany) RT-smartIMRT RW3-based 
cylindrical phantom of 30 cm diameter (Figure 44). The Octa was set in a cylindrical 
phantom in a vertical position to avoid the treatment coach, with its main receiving 
surface perpendicular to the incident beam and the 0 angle is identified as the horizontal 




to the machine isocentre.  
 
 
Figure 44. Snapshot of the Octa in the DosePoint RT-smartIMRT cylindrical phantom 
 
Figure 45. The Octa in a vertical orientation with respect to the linac. 
The radiation beams were generated by a Varian Clinac iX linac (Varian Medical System, 
Palo Alto, CA) equipped with a 120 Multi-Leaf Collimator (MLC) at the Illawarra Cancer 
Care Centre. The Octa was irradiated with 6 MV beams and measurements were taken 
for fields 10 x 10 cm2, 2x2 cm2 and 1x1 cm2. The gantry was rotated in a clockwise 
direction from 0° to 180° in steps 15° for the 10 x 10 cm2 field and in steps of 45° for the 




EBT3 films were used as a reference dosimeter to investigate the angular response of the 
Octa, and these were irradiated with the same beam used for the Octa. EBT3 films were 
cut into 4 x 4 cm2 squares and placed in the position of the Octa dosimeter in the 
cylindrical phantom. The films were scanned six times at the same position in the center 
of an EPSON scanner with a spatial resolution of 72 dpi. The last three scans were used 
for analysis the data to ensure thermal stability and consistency of the scanner. The 
ImageJ (National Institute of Health, USA) software package and Microsoft Excel 2016 
were used for data analysis.  
According to the procedure by Stansook et al. (Stansook et al., 2017), the calibration 
factors (a) were calculated from the ratio of the Octa response to the EBT3 response as a 
function of gantry angle Ɵ.  
                                  a (Ɵ) =
𝑂𝑐𝑡𝑎(𝜃)
𝐸𝐵𝑇3(𝜃)
   ---------------(6.1) 
For a given field size, the angular response ((C (Ɵ)) was the ratio of the calibration factor 
at any angle Ɵ to the calibration factor at 0° 




For correction the response in small fields for any angle, the dose map measured by the 
Octa ((Octa corrected (Ɵ)) was obtained by dividing the Octa response of the small square 
field ((Octa’ (Ɵ)) by the angular response C (Ɵ) of the large square field 10x10 cm2. 
            Octa corrected (Ɵ) =  
𝑂𝑐𝑡𝑎′(𝜃)
𝐶(𝜃)
 ----------------- (6.3) 
 
The study of the angular dependence for the Octa was expanded to include both the nine 
central pixels and all the remaining pixels in all of the arrays of the Octa. The correction 
factors calculated from the large square field 10x10 cm2 for 6MV energy photon beams 
were used to correct the angular response of the small square fields. In terms of the beam 




been calculated to improve the accuracy of the measured small field dose map.  
 
The angular relative response of the Octa was calculated for the nine central SVs for all 
given fields and for all the pixels of the Octa for the large field size 10 x 10 cm2. To show 
the effect of field size on the angular dependent response, the P-value of chi square test 
was used to compare the angular response for the same angles for different field sizes.  
The GEANT4 Monte Carlo toolkit was used to calculate the angular response of the nine 
central pixels of the Octa inside the cylindrical phantom. As in experimental set up, the 
Octa dosimeter was placed perpendicular to the incident beam inside the cylindrical 
phantom. The comparison between the GEANT4 calculation for the average of the 
angular responses of the nine central pixels and the experimental results was achieved. 
For any simulation in radiotherapy application, the Geant4 classes which must be 
involved to customize the materials geometry, quantities of particles and physics models 
that must be tracked at any interaction are: 
The G4VUserDetectorConstruction class, defines the materials, the geometries of these 
materials and their spatial positions such as the detectors and targets. 
The G4VUserPrimaryGeneratorAction class, defines the incident primary particles such 
as the particles type and their energy. 
The G4VUserPhysicsList class, defines the physics models and cross sections for any 
given simulation. There are many physics models the user can use the appropriate one for 
candidate simulation and three methods which can be implemented involved the 
Construct-particle method, the Construct process method and Set-Cut method. The 
particles which generated for simulation need to define the relevant particles, interaction 
models and the cut value to be applied that will not be tracked and stopped its deposit 
energy. 




at the end of each step. A step in Geant4 characterizes the transport of a particle between 
two points in space. A track is a snapshot of physic quantities of particle at a point along 
its path and a trajectory is a collection of tracks a long its path. The software Root (Root-
Data Analysis Framework) was used for data analysis to compare between the 
experimental results and the Geant4 simulation results. 
6.3 Results and discussion 
 
Figure 46 illustrates the angular response of the Octa for 6 MV beams as a function of the 
incidence angle between 0° and 180°.  The angular response was calculated from the 
average of the nine central diodes. For the 10 x 10 cm2 and for the 2 x 2 cm2, response is 
normalized to 0° gantry angle in Figure 46a, and for the 10 x 10 cm2, 2x 2 cm2 and 1x1 
cm2 response is normalized to 180° gantry angle in Figure 46b. This is because the 
irradiation of the EBT3 film for radiation incident angle 0 was lost for field size 1 x 1 cm2 
after the experiment.  
In the small fields incidence angles of 45°, 90°, 135° and 180°were selected to show the 
effect of the small fields’ sizes on the angular response of the Octa compared with the 
angular response of the large field.  
Figure 46 shows that for all the field sizes, the angular response of the Octa decreases as 
the incident beam angle increases from 0° to 90° with a minimum response at incidence 
angle 90° when the beam direction was parallel to the Octa plane and after 90° the 
response increases.  At 90°, the minimum angular response is 0.79 for 10 x 10 cm2, 0.85 
for 2 x 2 cm2 (Figure 46a). The error bars for the angular response in the 10 x 10 cm2 
showed a maximum standard deviation of 3% at 30° and in 2 x 2 cm2  showed a maximum 
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Figure 46: The averaged angular response of the nine central pixels of the Octa as a function of 
the incident beam angle for 6MV with 10 x 10 cm2, 2 x 2 cm2 and 1x1 cm2 fields. (a) The angular 
response of the 10 x 10 cm2 and 2 x 2 cm2 are normalized to 0° (b) and 1x1, 2x2, 10x10 cm2 are 





The results for the angular  response of the Octa for all the fields used are in agreement 
with those of a previous angular response investigation of MP512 (Stansook et al., 2017) 
and  Octa (Biasi et al., 2019) at all angles except at 90°.  
The comparison between the angular response for different field sizes at different 
incidence angles was achieved by calculating the P-value of chi-square for the same 
angles. There was no significant difference in the angular response between the field sizes 
10 x 10 cm2 and 2 x 2 cm2 where the P-value was 0.9991 or between the field sizes 10 x 
10 cm2 and 1 x 1 cm2 where the P-value was 0.9998. The results show agreement with 
the Stansook et al results where there was also no significant difference noted between 
the different field sizes. Therefore, the angular response correction factors of the field size 
10 x 10 cm2 can also be applied to the small fields of 2 x 2 and 1 x 1 cm2. 
Figures 47-50 illustrates the angular relative response for each pixel in the Octa array 
(Vertical, Horizontal, North West South East (NWSE), and South West North East 
(SWNE)) at incident angles between 0° and 180° steps in 15° for the 10 x 10 cm2 field.  
The fluctuation in the response attributes either to the functioning of each pixel in this 
experiment or to the fluctuation in the EBT3 films data. In the EBT3 films analysis, we 
did not use any filter to smooth the beam profile and the interpolation was used to 















Figure 47: The angular response for each pixel of the Octa arrays as a function of the incident 






Figure 48.  The angular response for each pixel of the Octa arrays as a function of the 












Figure 49. The angular response for each pixel of the Octa arrays as a function of the incident 
beam angle for 6MV with 10 x 10 cm2 FS for NWSE arrays. 
 
 
Figure 50. The angular response for each pixel of the Octa arrays as a function of the 





The incident radiation beam at 0° gantry angle was set to face the silicon wafer surface in 
the area of the central diode of the Octa. Between 0° and 90° gantry angles, the incident 
radiation beam needs to go through a longer path of silicon to reach the same central 
diode. The path of radiation through the silicon is 0.47 mm when at 180° gantry angle 
and 19 mm when at 90° gantry angle. So, the higher attenuation occurred when the beam 
passing through the silicon substrate and the perturbation that accompanied the lateral 
equilibrium and scattered secondary electrons is from the silicon substrate and from the 
air gap that surrounds the silicon substrate (Stansook et al., 2017 and Biasi et al., 2019). 
Between 90° and 180° gantry angle, the incident radiation beam was traversing the silicon 
wafer and the printed circuit board (PCB) to which the dosimeter wires are bonded (Biasi 
et al., 2019). 
Figure 51 illustrates the angular response of the nine central pixels of the Octa and Figure 
52 compares the average of the angular response of the nine central pixels and the 
GEANT4 simulation. 
 
Figure 51. GEANT4 calculation of the angular response coefficients for the nine central sensitive 






Figure 52: The average of the angular response coefficients for the nine central sensitive volumes 
of the Octa computed by the GEANT4 compared with experimental results. 
There was a good agreement between the GEANT4 and experimental results for the 
angular response of the Octa at different incidence angles. The small difference at 75° and 
105° occur because of the incidence particles traversing the through a long length of  PCB  
in the experimental set up, which was not allowed for the GEANT4 simulation because 
there was no accurate information on PCB composition. 
To investigate the validity of the angular correction factors of the 10 x 10 cm2 field for 
smaller fields, the beam profiles and penumbra measurements were achieved as 
following: 
 
The beam profiles for the 2 x 2 cm2 small fields were measured using the Octa at incidence 
angles from 0° angle to 180° angle in steps of 45°. The same beam profiles were also 
measured with EBT3 films, reproducing the same experimental conditions. 
The comparison between the beam profiles measured with the Octa and those measured 
with EBT3 films was achieved by comparing the full width of half maximum (FWHM) 
and (20%-80% max intensity) penumbra width. The difference in the FWHM between 








In tables 7-10, the comparison of beam profiles for 2 x 2 cm2 field size between the EBT3 
film and the Octa uncorrected at 0° angle shows the dose profile of the EBT3 film is wider 
than the Octa measurements. There is a lateral shift in the axes of the dose profile of the 
film, attributed to the position of the film during the experiment. However, the FWHM 
and (20%-80%) penumbra measurements from the EBT3 and Octa agree within ±0.5% 
and 0.5 mm, respectively. The Octa uncorrected response shows a slight dose profile 
distortion compared with the EBT3 film results. To correct the Octa data, the angular 
response correction factors for 10 x 10 cm2 field size were applied. After this correction 
is made, Tables 7-10 show a good improvement in the estimates of the FWHM and (20%-
80%) penumbra width from 3.5% and 1.30 mm to within 1 % and 1 mm for orthogonal 


























Table 7. FWHM and the (20%-80%) penumbra width difference for 2 x 2 cm2 field size at 6 MV 
between the EBT3 films and the Octa dosimeter before and after the large field size correction is 
applied for Vertical array of Octa. 
 
 Table 8. FWHM and the (20%-80%) penumbra width difference for 2x2 cm2 field size at 6MV 
between the EBT3 films and the Octa dosimeter before and after the large field size correction 
is applied for Horizontal array of Octa. 
 
 
                       VERTICAL
angle FWHM Diff R.Penumbra Diff L.Penumbra Diff
(mm) % (mm) (mm) (mm) (mm)
0 EBT3 film 19.94 3.85 3.85
Octa uncorrected 19.90 -0.18 3.40 -0.45 3.40 -0.45
45 EBT3 film 20.30 3.85 3.85
Octa uncorrected 19.50 -3.94 3.00 -0.85 2.70 -1.15
Octa corrected 20.10 -0.99 3.30 -0.55 3.15 -0.70
90 EBT3 film 19.70 3.00 2.00
Octa uncorrected 19.80 0.51 3.40 0.40 3.00 1.00
Octa corrected 19.70 0.00 2.40 -0.60 2.80 0.80
135 EBT3 film 19.95 3.10 3.60
Octa uncorrected 19.80 -0.75 1.95 -1.15 2.70 -0.90
Octa corrected 19.95 0.00 2.30 -0.80 2.85 -0.75
180 EBT3 film 20.30 3.50 3.70
Octa uncorrected 20.20 -0.49 2.70 -0.80 2.50 -1.20
Octa corrected 20.30 0.00 3.00 -0.50 2.60 -1.10
                           HORIZONTAL
angle FWHM Diff R.Penumbra Diff L.Penumbra Diff
(mm) % (mm) (mm) (mm) (mm)
0 EBT3 film 20.30 3.15 3.50
Octa uncorrected 20.40 0.49 2.85 -0.30 3.20 -0.30
45 EBT3 film 28.35 3.85 4.73
Octa uncorrected 28.20 -0.53 3.30 -0.55 4.35 -0.37
Octa corrected 28.35 0.00 3.45 -0.40 4.65 -0.07
135 EBT3 film 28.35 3.68 4.90
Octa uncorrected 28.20 -0.53 2.70 -0.98 3.60 -1.30
Octa corrected 28.35 0.00 3.10 -0.58 3.80 -1.10
180 EBT3 film 20.30 2.98 3.15
Octa uncorrected 20.10 -0.99 2.30 -0.68 2.40 -0.75




Table 9. FWHM and the (20%-80%) penumbra width difference for 2x2 cm2 field size at 6MV 
between the EBT3 films and the Octa dosimeter before and after the large field size correction 
is applied for NWSE array of Octa. 
 
Table 10. FWHM and the (20%-80%) penumbra width difference for 2x2 cm2 field size at 6MV 
between the EBT3 films and the Octa dosimeter before and after the large field size correction is 
applied for SWNE array of Octa. 
 
 
                             NWSE
angle FWHM Diff R.Penumbra Diff L.Penumbra Diff
(mm) % (mm) (mm) (mm) (mm)
0 EBT3 film 26.50 3.00 4.50
Octa uncorrected 26.40 -0.38 2.80 -0.20 4.40 -0.10
45 EBT3 film 27.75 5.00 5.00
Octa uncorrected 27.52 -0.83 3.87 -1.13 4.73 -0.27
Octa corrected 27.74 -0.05 4.09 -0.92 4.95 -0.05
90 EBT3 film 28.00 4.70 6.20
Octa uncorrected 28.38 1.36 3.66 -1.05 4.95 -1.26
Octa corrected 28.00 0.00 4.40 -0.30 5.32 -0.88
135 EBT3 film 27.60 3.85 6.00
Octa uncorrected 28.17 2.05 3.44 -0.41 4.30 -1.70
Octa corrected 27.60 0.00 3.75 -0.10 4.58 -1.42
180 EBT3 film 26.25 4.00 4.00
Octa uncorrected 26.23 -0.08 3.44 -0.56 3.23 -0.78
Octa corrected 26.25 0.00 3.86 -0.14 3.60 -0.40
                         SWNE
angle FWHM Diff R.Penumbra Diff L.Penumbra Diff
(mm) % (mm) (mm) (mm) (mm)
0 EBT3 film 26.50 4.00 4.00
Octa uncorrected 26.40 -0.38 3.90 -0.10 3.80 -0.20
45 EBT3 film 27.50 5.00 5.25
Octa uncorrected 27.09 -1.49 3.66 -1.35 4.30 -0.95
Octa corrected 27.52 0.07 5.00 0.00 4.30 -0.95
90 EBT3 film 28.45 4.10 5.00
Octa uncorrected 27.95 -1.76 3.00 -1.10 5.16 0.16
Octa corrected 28.30 -0.53 3.96 -0.14 4.99 -0.01
135 EBT3 film 27.50 4.00 4.70
Octa uncorrected 27.95 1.64 3.44 -0.56 3.90 -0.80
Octa corrected 27.75 0.89 3.70 -0.30 4.21 -0.49
180 EBT3 film 26.50 4.00 3.50
Octa uncorrected 25.62 -3.32 3.23 -0.78 3.23 -0.28




For  field size 1 x 1 cm2, the beam profiles of the Octa uncorrected at 45°, 90°, 135° and 
180° in terms of the full width of half maximum (FWHM) and (20%- 80%) penumbra 
width show a distortion with respect to the EBT3 films responses as detailed in Tables 
11-14. The slight lateral shift in the axis of the dose profiles between the Octa dose 
profiles and the EBT3 dose profiles is because of the position of the films during the 
experiment. The dose beam profiles of the EBT3 films are wider than the Octa dose 
profile for all angles. There are no beam profiles for 1 x 1 cm2 field size at 0° angle 
because it was lost in the hospital during the experiment. There are 11% and 2 mm 
discrepancy between Octa uncorrected and EBT3 film results, respectively in FWHM and 
the (20%-80%) penumbra width for orthogonal arrays and within 10% and 1 mm for 
diagonal arrays. A good improvement in the FWHM and (20%-80%) penumbra width is 
gained after applying the 10x10 cm2 field size correction factors as in Tables 11-14. 
FWHM and the (20%-80%) penumbra width after the correction is applied are within 8% 















Table 11. FWHM and the (20%-80%)  penumbra width for the EBT3 films for the Vertical array 
of Octa measurements before and after applying the correction factors of field size 10 x 10 cm2 
with the differences for 1 x 1cm2 field size all at 6MV. 
 
Table 12. FWHM and the (20%-80%)  penumbra width for the EBT3 films for the Horizontal 
array of Octa measurements before and after applying the correction factors of field size 10 x 






                       VERTICAL
angle FWHM Diff R.Penumbra Diff L.Penumbra Diff
(mm) % (mm) (mm) (mm) (mm)
45 EBT3 film 9.70 2.90 2.90
Octa uncorrected 8.85 -8.76 2.40 -0.50 2.00 -0.90
Octa corrected 9.00 -7.22 2.60 -0.30 2.80 -0.10
90 EBT3 film 9.80 2.80 2.80
Octa uncorrected 8.70 -11.22 2.25 -0.55 2.25 -0.55
Octa corrected 9.00 -8.16 2.40 -0.40 2.25 -0.55
135 EBT3 film 9.80 2.63 2.45
Octa uncorrected 9.30 -5.10 2.10 -0.53 2.10 -0.35
Octa corrected 9.50 -3.06 2.30 -0.33 2.40 -0.05
180 EBT3 film 10.15 2.80 2.80
Octa uncorrected 9.90 -2.46 2.10 -0.70 2.20 -0.60
Octa corrected 10.00 -1.48 2.50 -0.30 2.20 -0.60
                           HORIZONTAL
angle FWHM Diff R.Penumbra Diff L.Penumbra Diff
(mm) % (mm) (mm) (mm) (mm)
45 EBT3 film 14.70 4.00 4.25
Octa uncorrected 14.10 -4.08 2.40 -1.60 2.40 -1.85
Octa corrected 14.30 -2.72 2.70 -1.30 2.80 -1.45
135 EBT3 film 14.35 3.15 3.50
Octa uncorrected 14.10 -1.74 2.40 -0.75 2.40 -1.10
Octa corrected 14.20 -1.05 3.00 -0.15 2.70 -0.80
180 EBT3 film 10.50 2.28 2.45
Octa uncorrected 9.90 -5.71 1.95 -0.32 2.10 -0.35




Table 13. FWHM and the (20%-80%)  penumbra width for the EBT3 films for the NWSE array 
of Octa measurements before and after applying the correction factors of field size 10 x 10 cm2 
with the differences for 1 x 1cm2 field size all at 6 MV. 
 
Table 14. FWHM and the (20%-80%)  penumbra width for the EBT3 films for the SWNE array 
of Octa measurements before and after applying the correction factors of field size 10 x 10 cm2 
with the differences for 1 x 1cm2 field size all at 6MV. 
 
 
                             NWSE
angle FWHM Diff R.Penumbra Diff L.Penumbra Diff
(mm) % (mm) (mm) (mm) (mm)
45 EBT3 film 13.50 3.50 4.00
Octa uncorrected 12.40 -8.15 3.23 -0.28 3.01 -0.99
Octa corrected 12.80 -8.16 3.50 0.00 3.80 -0.20
90 EBT3 film 13.50 3.75 3.75
Octa uncorrected 12.69 -6.04 3.44 -0.31 3.23 -0.52
Octa corrected 12.80 -5.19 3.70 -0.05 3.70 -0.05
135 EBT3 film 13.50 3.50 4.00
Octa uncorrected 12.90 -4.44 3.44 -0.06 2.96 -1.04
Octa corrected 13.20 -2.22 3.50 0.00 3.50 -0.50
180 EBT3 film 13.50 3.50 3.50
Octa uncorrected 12.04 -10.81 2.80 -0.71 2.80 -0.71
Octa corrected 12.40 -8.15 2.91 -0.59 3.00 -0.50
                         SWNE
angle FWHM Diff R.Penumbra Diff L.Penumbra Diff
(mm) % (mm) (mm) (mm) (mm)
45 EBT3 film 13.00 3.50 3.75
Octa uncorrected 12.04 -7.38 3.44 -0.06 3.44 -0.31
Octa corrected 12.80 -1.54 3.50 0.00 3.70 -0.05
90 EBT3 film 13.75 3.75 4.25
Octa uncorrected 12.26 -10.87 3.01 -0.74 3.23 -1.03
Octa corrected 12.90 -6.18 3.23 -0.53 3.44 -0.81
135 EBT3 film 13.50 3.50 3.25
Octa uncorrected 12.90 -4.44 3.01 -0.49 3.23 -0.03
Octa corrected 13.20 -2.22 3.25 -0.25 3.25 0.00
180 EBT3 film 13.00 3.00 3.00
Octa uncorrected 11.83 -9.04 2.80 -0.21 2.37 -0.64




The angular response for the Octa is attributed to the configuration of the diodes of the 
Octa and the surrounding materials that causes perturbation to incident radiation. For 
more optimization, Monte Carlo simulations can be used to evaluate the angular response 
of the Octa. The comparison between the Monte Carlo simulations and the Octa 
measurement can improve the design of the Octa. We could not deliver a full treatment 
plan to the phantom to correct it by using the correction factors of this work because of 
COVID-19 restriction. For future work, we recommend delivering a modified treatment 
plan for the cylindrical phantom and measuring the dose with the Octa when corrected by 
applying the measured correction factors obtained in this work.  
6.4 Conclusion 
 
This study investigated the angular response of the Octa array for 6 MV photons in a 
cylindrical phantom when the incident radiation beams are perpendicular to the Octa 
plane. The angular response of the Octa at different incidence angles for the central SVs 
and for the vertical, horizontal, NWSE sand SWNE array are significantly different from 
each other between 0° and 180° incidence angles. The maximum reduction in the angular 
response for the nine central pixels and for all the arrays of the Octa is at 90° as shown in 
Figures 47- 50. There was no significant difference in the angular response for the field 
sizes of 10 x 10 cm2 or 2 x 2 cm2 or 1 x 1 cm2 where the P-value were 0.9991 and 0.9998, 
respectively. There was a good agreement between the GEANT4 simulation and the 
experimental results for the angular response of the Octa. The angular response at 90° 
incident angle needs more investigation for different field sizes. The angular response 
correction factors of 10 x 10 cm2 large field size can improve the beam profiles for the 1 
x 1 cm2 and 2 x 2 cm2 small fields at different incidence angles. These correction factors 




and 1.5 mm, and within 2% and 1.4 mm for  field sizes 1 x 1 cm2 and 2 x 2 cm2, 
respectively. The pixels configuration affects the Octa measurements at some critical 
angles, which leads to the angular response of the Octa dosimeter. This study can support 
the suggestion to use the square field size 10 x 10 cm2 correction factors to correct the 
angular response of the Octa at different angles for VMAT and IMRT. These latter 
therapies used these small fields to deliver maximum doses to tumours and could use the 






















Chapter 7 – The angular dependence of the Octa in a custom-
made phantom designed for quality assurance of stereotactic 
body radiation therapy for vertebral metastases  
 
 
This chapter explores the angular dependent sensitivity of the Octa inside a custom-made 
phantom poly-methyl-methacrylate (PMMA) spine. The phantom was custom-made for 
measurements relevant to ensure the quality of stereotactic body radiation therapy 
(SBRT) for vertebral metastases.  
7.1 Introduction 
 
In chapter 6 it was demonstrated that, when the Octa was parallel to the treatment couch 
and the linac gantry rotates between 0 and 360 degrees, the sensitivity of the Octa to 
incident radiation is minimized when the array parallel to incident radiation (i.e at gantry 
angles 90° and 270°). The Octa in the custom-made phantom fabricated in chapter 5 is 
perpendicular to the treatment couch, and as the linac gantry rotates between 0 and 360 
degrees, the Octa is always 90 degrees with respect to incident radiation (i.e. beam central 
axis is along of the Octa plane).  
The aim of this chapter was to investigate the angular response of the Octa inside the 
custom-made phantom fabricated in chapter 5 and calculate the correction factors to 
compensate for that dependence.  
7.2 Methodology 
 
 The custom-made phantom was imaged with the Octa and without the Octa (Figure 53) 
by using a Siemens Somatom 64 slice computed tomography (CT), using a slice thickness 
of 2 mm at the Illawarra Cancer Care Centre ICCC (Wollongong Hospital, NSW, 
Australia). CT images were transferred to a commercial treatment planning system (TPS), 




was used for dose calculations. A comparison was made between calculations on the CT 
scan of the phantom with the Octa and those on the CT scan of the phantom without the 
Octa. 
 
                               (a) 
     
                            (b) 
Figure 53. (a) The custom-made phantom with the Octa and (b) image of  treatment planning 
for the phantom.  
Doses calculations with  the TPS were exported into  a Microsoft “Excel” spreadsheet as 
shown in Figure 54 for a specific gantry angle (gantry 0). The beam profiles for all arrays 
of the Octa were extracted from these data by identifying the position of the Octa in the 
beam maps. The central pixels of the Octa were placed in the isocentre of the radiation 
beam.  
 






First, for the Octa response calibration, the radiation beams were targeted perpendicular 
on the Octa inside the phantom were programmed to distribute the dose equally by using 
field size 10 x 10 cm2, 100 MU, SSD 95 cm and photon energy 6 MV at depth of 5 cm as 
in Figure 55. Then, the benchmark for the Octa response was achieved by the calculating 
the dose (Gy) from TPS and the Octa charges (in nC). 
 
                   Figure 55. Calibration of the Octa dosimeter in the PMMA spine phantom 
The irradiation beams for the angular dependence study were produced with a photon 
energy of 6 MV with a flattening filter (FF) or flattening filter free (FFF) at various angles. 
For 6 MV FF (dose rate 600 MU/min), the phantom was irradiated from 0°-360° beam 
incidence angle, in steps of 10° delivered with a field size of 10 x 10 cm2, 100 MU. For 
photon energy 6 MV FFF (dose rate 1400 MU/min), the spine phantom irradiated with 
100 MU, field size 10 x 10 cm2 and SSD 95 cm at angles from 0° to 360° in steps of 45° 
(Figure 56). The photon beams were produced by a TrueBeam (Varian Medical Systems) 
medical accelerator (linac). The angular response correction factors were calculated by 
using the equations (6.1, 6.2 and 6.3) and the experiments were conducted at St George 





Figure 56. The incident beams angles for irradiating the PMMA spine phantom to 
calculate its angular response. 
For small field dosimetry, the angular correction factors of the Octa for large field for 
photon energy 6 MV FFF were applied to correct the small field 1 x 1 cm2 100 MU 6 MV 
FFF at angles from 0° to 360° in steps of 45°.  
For spinal cord pre-treatment QA applications, the PMMA spine phantom and the Octa 
dosimeter are used at the dose level that will be delivered to the patient. VMAT 6 MV 
FFF plans are used to treat small lesion in a spinal cord surrounded by critical structures. 
The verification procedure includes the patient plan delivery calculated by the TPS to the 
QA spine phantom and then measuring the dose by using the Octa dosimeter to compare 
the calculated and measured dose. 
7.3 Results and discussion 
 
The Octa dosimeter has insignificant effect on the homogeneous PMMA spine phantom. 
The dose was calculated by using the TPS which extracted for the average of the nine 




PMMA spine phantom at different angles for photon energy 6 MV FF ( Figure 58). For 
the measured dose by the Octa, five pixels of the vertical array were chosen to measure 
the doses at these pixels. Pixel#2 located close to the beginning of the array; pixel#128 
located close to the ending of the array; pixels #64, 65, 66 are in the centre of the array. 
 
Figure 57. The dose measured as a function of radiation incident beams angles from 0° to 360° 
in steps 10° for photon energy 6MV FF and field size 10 x 10 cm2 from the central nine pixels 






Figure 58. The dose measured as a function of radiation incident beams angles from 0° to 360° 
in steps 10° for photon energy 6MV FF and field size 10 x 10 cm2 from the five pixels of the 
Vertical array of the Octa (pixel#2 located close to the beginning of the array; pixel#128 located 
close to the end of the array; pixels#66, 65, 64 located in the middle of the array). 
 
In the Figure 57, the dose calculated dose by the TPS for the central pixels are a slightly 
increased from 0° angle to 90° angle, then the dose slightly decreases at 110° angle then  
drops sharp from 120°-140°. After 140° a slight increase until it reaches a central 
maximum at 180° angle. The maximum calculated dose is attained at 90° (or 270°) angle 
where the incident radiation beams have lower attenuation from the phantom. Figure 58 
is the actual Octa response and is of course very similar in shape to the  TPS target dose 
profile. For the measured dose by the Octa (Figure 58), the overall response is similar to 
the TPS response, but the maximum response is found at 100° angle and is lower than 
expected,  attributed to a misalignment of the isocentre of the radiation beam with respect 
to the centre of the Octa. This increase and decreases in the dose profile are attributed to 
the phantom shape in addition to the assembly materials of the dosimeter.  From 0° beam 




140° the beam enters through the flat lower surface of the phantom at 140° angle the 
phantom lower corner and  the dosimeter edge are in the beam path and the patient couch 
also starts to intrude at this angle where there would be the maximum attenuation for the 
photon beams. At 180° beam incidence angle, the couch and PCB lie directly in the path 
of the incident radiation beams before reaching the SVs of the Octa so the measured dose 
is expected to  be lower than at the  0° beam incidence angle.  
The response of pixel#2 is opposite to pixel#128 where each of them is lie in the opposite 
direction of the incidence beam. When the incident radiation beam is at 0° angle, pixel#2 
is higher up and  pixe#128 is lower down in the Octa array so pixel#2 has a higher 
response than pixel#128. Then, at 90° angle they have near-identical response (since they 
are both the same distance from the beam source)while after 90 angle they have opposite 
response. At 180° angle, pixel#128 has a higher response than pixel#2 because pixel#128 
is closer to the beam source while pixel#2 on the other side of the Octa array. 
Furthermore, the calculated dose from the TPS and the measured dose from the Octa were 
performance for photon energy 6 MV FFF (see Figure 59 and Figure 60). The phantom 
was irradiated with field size 10 x 10 cm2 from 0° to 360° angle in steps of 45°, the 
response of the Octa for photon energy 6 MV FFF is similar to the Octa response for 
photon energy 6 MV FF. The difference is just the measured and calculated dose for 
photon beam 6 MV FFF is lower than the measured and calculated dose for 6 MV FF. In 
general, the calculated dose of the TPS was slightly higher than the dose measured by the 






                 Figure 59. The dose  from TPS  for photon energy 6 MV FFF 
 
 
Figure 60. The dose from the Octa. For photon energy 6MV FFF.#2 line = Pixel #2 dose 





As estimated from Figure 57 and Figure 58 , the angular dependence of the Octa inside 
the PMMA spine phantom for two arrays of the Octa sampling volumes (the Vertical and 
the Horizontal arrays) was calculated (see Figure 61and Figure 62 for photon energy 6 
MV FF) for all 129 pixels of each array (the line connected just the chosen pixels). 
 
Figure 61. The angular dependence for all 129 pixels in Vertical array of the Octa for photon 







Figure 62. The angular dependence for all 129 pixels in Horizontal array of the Octa for photon 
energy 6 MV FF. 
The angular response of the Octa’s Vertical and Horizontal arrays as a function of 
incidence radiation beams for photon energy 6 MV FF is approximately flat from 0° to 
110° angle with a slight climb in the response between 90 and 110 then a slight drop in 
response after 110° degree. From 180° to 350°, the angular response is nearly a mirror-
image of the 0° to 180°.  
The outcomes of calculating the angular response of the Octa Vertical and Horizontal 
arrays in photon beams of 6 MV FFF and 10 x 10 cm2 field size are illustrated in Figure 





Figure 63.The Octa angular dependence for 129 pixels in Vertical array for photon energy 6MV 
FFF. 
 







The angular response of the Octa array from 0° angle to 90° angle is approximately flat, 
then it reduces until reaching its minimum reduction at 180° angle. From 180° angle, the 
angular response slightly increases until 360°. Both halves of the phantom are identical, 
however, the angular response of Octa array in the second half of the beam incidence 
angle range is lower than the first half because of misalignment of the isocentre of the 
radiation beam in relation to the centre of the Octa inside the PMMA spine phantom. By 
using equation 6.3, the correction factors can be calculated and applied for all the pixels 
to correct the Octa readings. 
The beam profiles as a function of the irradiation incident beams along the Vertical central 
line in the PMMA spine phantom at different incidence angles from 0° to 165° with the 
Octa raw and the Octa corrected for 6 MV FF illustrated in Figures 65-76. 
 
 
Figure 65: The beam incidence profiles of the central vertical line of the PMMA spine phantom 
at 0° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses, 
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors 






Figure 66: The beam incidence profiles of the central vertical line of the PMMA spine phantom 
at 15° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses, 
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors 
for 6MV FF. 
 
 
Figure 67: The beam incidence profiles of the central vertical line of the PMMA spine phantom 
at 30° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses, 
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors 






Figure 68: The beam incidence profiles of the central vertical line of the PMMA spine phantom 
at 45° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses, 
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors 
for 6MV FF. 
 
 
Figure 69: The beam incidence profiles of the central vertical line of the PMMA spine phantom 
at 60° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses, 
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors 







Figure 70: The beam incidence profiles of the central vertical line of the PMMA spine phantom 
at 75° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses, 
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors 
for 6MV FF. 
  
 
Figure 71: The beam incidence profiles of the central vertical line of the PMMA spine phantom 
at 90° irradiated incidence angles. The data points in 3 colors show comparison of the TPS doses, 
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors 






Figure 72: The beam incidence profiles of the central vertical line of the PMMA spine phantom 
at 105° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses, 
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors 
for 6MV FF. 
 
Figure 73: The beam incidence profiles of the central vertical line of the PMMA spine phantom 
at 120° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses, 
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors 






Figure 74: The beam incidence profiles of the central vertical line of the PMMA spine phantom 
at 135° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses, 
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors 
for 6MV FF. 
 
Figure 75: The beam incidence profiles of the central vertical line of the PMMA spine phantom 
at 150° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses, 
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors 






Figure 76: The beam incidence profiles of the central vertical line of the PMMA spine phantom 
at 165° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses, 
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors 
for 6MV FF. 
 
For small dosimetry, the calibration factors for large field 10 x 10 cm2 were used to correct 
the Octa readings for small fields of 1 x 1 cm2 for 6 MV FFF. Figures 77-92 show the 
changes in the beam profiles of the vertical central line of the Octa inside the PMMA 
spine phantom at angles from 0° to 315° in steps of 45°. In addition, the Figures illustrate 
the difference between the calculated, measured dose and the corrected dose for the 
Horizontal array of the Octa for 1 x 1 cm2 corrected by 10 x 10 cm2 for photon energy 6 
MV FFF. 
Figures 77 to 92 show slight discrepancies between the “corrected” dose measured by the 
Octa and the dose calculated by the TPS. This error attributed to the difference in 
calibration between 6MV FFF and 6MV FF beam profiles. Furthermore, there are a shift 
in the central maximum position along the distance x-axis because of a slight 
misalignment of geometric center of the Octa and the isocenter of the radiation beam 






Figure 77: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 0° 
incidence angles with the Octa measurements and with the Octa corrected measurements 
comparing with the TPS of the Octa Vertical array. 
 
 
Figure 78: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 45° 
incidence angles with the Octa measurements and with the Octa corrected measurements 







Figure 79: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 90° 
incidence angles with the Octa measurements and with the Octa corrected measurements 
comparing with the TPS of the Octa Vertical array. 
 
 
Figure 80: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 135° 
incidence angles with the Octa measurements and with the Octa corrected measurements 
comparing with the TPS of the Octa Vertical array. 
 






Figure 81: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 180° 
incidence angles with the Octa measurements and with the Octa corrected measurements 
comparing with the TPS of the Octa Vertical array. 
 
 
Figure 82: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 225° 
incidence angles with the Octa measurements and with the Octa corrected measurements 







Figure 83: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 270° 
incidence angles with the Octa measurements and with the Octa corrected measurements 
comparing with the TPS of the Octa Vertical array. 
 
 
Figure 84: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 315° 
incidence angles with the Octa measurements and with the Octa corrected measurements 







Figure 85: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by 
the Octa Horizontal array sensitive volumes for 0° radiation incidence beam. 
 
 
Figure 86: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by 










Figure 87: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by 
the Octa Horizontal array sensitive volumes for 90° radiation incidence beam. 
 
 
Figure 88: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by 






Figure 89: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by 
the Octa Horizontal array sensitive volumes for 180° radiation incidence beam. 
 
 
Figure 90: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by 
the Octa Horizontal array sensitive volumes for 225° radiation incidence beam. 
 






Figure 91: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by 
the Octa Horizontal array sensitive volumes for 270° radiation incidence beam. 
 
 
Figure 92: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by 
the Octa Horizontal array sensitive volumes for 315° radiation incidence beam. 
 












The Octa silicon detector with its small SVs diodes was placed to zero angle direction of 
the beam in the PMMA spine phantom where the maximum reduction in the angular 
response for the Octa as in the chapter 6 (i.e. beam central axis is along of the Octa plane). 
Preliminary results in Figures 61, 62, 63 and 64 illustrate that the angular response for 
photon energy 6 MV FF and 6 MV FFF is reasonably flat from 0° to 90° incident beam 
angle because the phantom is part of the cylinder for 0 - 90 degree angles, and angles in 
this range have only a slightly impact on the measurements produced by the Octa. After 
90° angle, the angular response reduces until reaching 180° angle where there is a 
minimum response. In this position, the couch, and the assembly materials of the Octa 
intercept the incident radiation beams. For small field dosimetry, the Octa for photon 
energy 6 MV FFF needs to calibrate at 6 MV FFF not 6 MV FF due to difference in the 
photon spectrum in place of the Octa. 
The investigations confirmed the Octa dosimeter can provide high resolution maps of 
dose distribution, with the Vertical and the Horizontal arrays providing 0.3 mm resolution 
and the NWSE and SWNE arrays providing 0.43 mm resolution, whereas the TPS data is 
provided in  0.7813 mm increments.  
The measurements gained in this study showed that the Octa, a 2D monolithic silicon-
diode array can be used in a PMMA phantom in a vertical position with Octa plane along 
the beam to accurately measure the received dose. The Octa provides information about 
the dose distribution with small spatial resolution, comparable to the resolution of the 
TPS. Therefore, there is potential to use the Octa for machine specific QA and spinal cord 






Chapter 8 - Conclusions 
 
 
Globally, half of all cancer patients require radiation therapy. Radiation therapy demands 
adequate quality assurance (QA) to ensure the treatment is safe and effective for patients. 
The success of QA largely depends on adequate radiation sensors (dosimeters being 
available and properly used. 
In this thesis, the candidate considered two dosimeters recently designed at the Centre for 
Medical Radiation Physics, University of Wollongong, and investigated their applications 
in scenarios that offer particular challenges in modern x-rays external-beam radiation 
therapy. 
The following is a summary of the results of this thesis by reference to the original aims: 
Part 1: the MOSkin, design improvement and applications. 
Aim1: Optimizing the MOSkin for measurements of dose due to medical imaging. 
Chapter 3 describes how the design of the MOSkin,  a point dosimeter with 0.07 mm water 
equivalent depth of dose measurements as required by ICRU for skin dosimetry, was 
improved, to enhance its sensitivity to ionizing radiation. Enhanced sensitivity was 
achieved by the changing the thickness of the sensitive volume (the silicon dioxide under 
the gate oxide) and tuning the external bias applied on the gate electrode during 
irradiation. Chapter 3 also explored the  effect of boron implantation dose under the 
silicon of the gate electrode.  
As anticipated, it was shown that MOSkins with a thicker silicon dioxide had enhanced 
sensitivity and a higher initial threshold voltage, which, for a particular maximum Vth 
measured by the reader in use, reduce the MOSkin lifespan. The new technological 
approach of implanting boron dose under the gate before growing the silicon  dioxide 




lifespan. In summary, MOSkin sensitivity was determined by the thickness and by the 
quality of the silicon dioxide, and the boron implantation did not create instability of the 
threshold voltage. The spread-out of MOSkin sensitivity, for MOSkins in the same batch, 
was ± 1%. This would allow to prescribe a single sensitivity for all  MOSkin fabricated 
within the same batch. 
Aim 2: Explore the characteristics of a novel eXaSkin bolus radiation therapy using 
the MOSkin.  
In chapter 4, the candidate used MOSkins was used to evaluate the characteristics of a 
novel eXaSkin bolus. First, the candidate investigated the dose build-up produced by the 
eXaSkin, for 6 MV photon beams. The surface and build up dose characteristics of 
eXaSkin and the percentage surface dose measurements for different oblique incident 
beams were investigated by comparison with solid water-equivalent materials. 
Measurements were achieved using MOSkin dosimeter and compared with an advanced 
Markus chamber. The outcomes of this method revealed that the dmax of eXaSkin at 6 MV 
was approximately 0.9 cm. This bolus also displays a higher dose in the build-up region 
between 2 and 10 mm depth and a higher dose than solid water-equivalent slabs with 
oblique incidence angles beams.  
The advanced applications of eXaSkin bolus, an alternative to commercial Superflab 
tissue-equivalent bolus, for 6 MV photon-beam radiotherapy were studied. Clinical plan 
for head-and-neck were delivered with both static fields and the volumetric modulated 
arc therapy (VMAT) technique, to an anthropomorphic phantom in three situations: with 
no bolus on the phantom’s surface, with Superflab, and with eXaSkin. In each situation, 
the dose to a central planning target volume (PTV) was measured with an ionization 
chamber in the nasopharynx region, and the doses to the skin at three locations within the 




Measurements were compared to calculations with the treatment planning system (TPS). 
The MOSkinTM results under the eXaSkin displayed a good agreement (2 - 6 %) with 
calculations for VMAT. Slight disagreements in dose levels were explained by 
suboptimal adherence of Superflab to the phantom’s surface as well as difficulties in 
accurately reproducing its placement between the imaging and the radiotherapy treatment 
time intervals. In all situations, dose measured at the central target agreed to within 1% 
with calculations.  eXaSkin was shown to have superior adaptation to the phantom’s 
surface, creating minimal bubbles or air gaps between the skin surface and bolus, 
promoting accurate location and reproducibility of set-up conditions. eXaSkin with its 
higher-density material, offers an adequate dose build-up to achieve full skin dose with 
less material thickness than Superflab. The outcomes of this study confirmed that 
MOSkinTM dosimeter with eXaSkin bolus can provide advanced tools for skin 
radiotherapy QA and accurate dose delivery to the skin target, respectively.  
Part 2: the Octa and its applications 
Aim 3: In stereotactic radiation therapy for vertebral metastases, a dosimeter should 
measure dose distributions in the horizontal plane, rather than in the coronal plane. 
This aim was to design the ‘spine phantom’, a phantom custom-made to 
accommodate the Octa in the horizontal plane. 
A spine phantom was designed and manufactured in the University of Wollongong 
(NSW, Australia) suitable for the Octa dosimeter. The spine phantom was constructed 
from polymethyl methacrylate (PMMA) with a density of 1.19g/cm3 and designed to 
present cross-section of the spinal cord in horizontal plane. The dimensions of the PMMA 
spine phantom with the Octa located it between the components sections were illustrated 
in chapter 5. This phantom with the Octa dosimeter in its horizontal plane was used to 




the first spine phantom with 2D monolithic dosimeter for real time dosimetry replacing 
EBT film currently used for spinal tumours treatment delivery QA 
Aim 4: Explore the Octa response as a function of the angle of incidence of radiation 
beams, in a standard cylindrical geometry, with the array measuring in the frontal 
plane. 
Advanced radiotherapy treatments employ small fields to deliver maximum dose to the 
target and minimum dose to nearby healthy tissues. The main challenges for the 
measurements in small radiation fields that are addressed by code of practice (CoP) are 
partial occlusion of the primary source; loss of charged particle equilibrium (influenced 
by details of the radiation beams and the materials it is penetrating) and dimensions of 
dosimeter with respect to the radiation field (related to type and details of the dosimeter 
in use).  
 The Octa is a 2D silicon array dosimeter with 0.3 mm and 0.43 mm pitch for orthogonal 
and diagonal arrays, respectively. To use the Octa for delivered dose verification in small 
radiation fields, its angular response was investigated. Chapter 6 displayed the Octa 
angular dependence by using 10 x 10 cm2 field size 6MV in a cylindrical phantom and 
calculating the correction factors from 0° to 180° steps in 15°. Then, an attempt was made 
to apply the correction factors from the large square field response to modify small square 
field data. The incident radiation beams were varied in a plane perpendicular to the Octa 
plane. The EBT3 films extracted beam profiles for all square field sizes and the Octa 
measurements were used to calculate the angular response of the Octa. The correction 
factors from the large field 10x10 cm2  were calculated. There was no significant 
difference in the angular response between the square field sizes. A good agreement was 
recorded between the GEANT4 simulation and the experimental results for angular 




more investigation for different field sizes. Correction factors were applied to correct the 
6MV small square fields. The FWHM and the (20% - 80 %) penumbra measurements 
were used to compare between the EBT3 films beam profiles and the Octa readings before 
and after the correction. These correction factors improved the FWHM and the (20 %-80 
%) penumbra width measurements to within 8 % and 1.5mm, and within 2% and 1.4 mm 
for 1x1 cm2 and 2x2 cm2, respectively. The accuracy in data collected by the Octa during 
irradiation will provide accuracy in data measured during patient treatments, in turn, the 
Octa can be used in QA of advanced radiotherapy as a reference dosimeter. 
Aim 5: Explore the Octa response as a function of the angle of incidence of radiation 
beams, in the ‘spine phantom’ geometry, with the array measuring in the horizontal 
plane. 
A new phantom was designed at the CMRP, the spine phantom, to accommodate the Octa 
so that it could measure dose distribution in the horizontal plan. The phantom was 
fabricated from the PMMA with density 1.19g/cm3. In chapter 7 the candidate has 
performed a study of the perturbation effect of the Octa dosimeter in the homogeneous 
phantom. The beam profiles were extracted from the TPS and a comparison between the 
phantom with and without he Octa was achieved. The results show that the Octa has no 
significant influence on the dose perturbation in homogeneous phantom. Preliminary 
results for the angular response were calculated for the nine central pixels of the Octa. 
Experiments were conducted for 10x10 cm2 6MV FF and 6MV FFF to calculate the 
angular response. There are differences in spatial resolution of the Octa along linear arrays 
profiles (0.3) and the extracted result from the central TPS (0.7813 mm). In chapter 6, the 
minimum angular response was where the Octa plane was at 90° to the incident beam this 
is represents 0° angle for the PMMA spine phantom. The length of the path that the 




volume may be different. The PMMA spine phantom has an arch shape at its top (from 
0° to 90° angle whereas from 90° to 180° it has a flat surface. Calculations were done to 
determine the correction factors from initial large field measurements. These were used 
to modify the raw dose data for small fields for use in advanced radiotherapy treatments. 
In this thesis many materials, devices, systems and programs were used as tools to 
improve QA program for advanced radiotherapy treatments. Our results show that 
MOSkins with eXaSkin bolus can be used as a point silicon dosimeter for skin dosimetry 
and could potentially be applied successfully for dosimetry on a body surface or in other 
region of high dose gradient in treating other parts of the human body with different types 
of modalities of radiation treatments.  
The Octa, a 2D dosimeter, when used with the new PMMA spine phantom and cylindrical 
phantom was shown to be useful for various radiotherapy QA program. The angular 
response of the Octa and spine phantom or Octa and cylindrical phantom systems needs 
comprehensive study for determining the intrinsic angular response factors. This was 
achieved by arranging the incident radiation beams to be applied at accurately known 
angles in a plane parallel to Octa plane in both phantoms by using EBT3 films and 
calculating the angular response factors. In addition, by using the spine phantom with 
different radiation treatments modalities which include or exclude the spinal cord 
treatment in radiotherapeutic spine treatments, it was demonstrated that these devices and 
systems are realistic and accurate prospects for a spine radiotherapy QA program. For the 
cylindrical phantom, advanced clinical radiotherapy plans were delivered to the Octa to 
produces accurate measurements the dose by the Octa corrected appropriately by using 
the experimental correction factors. Finally, Monte Carlo simulation verified the results 
of the experiments by using same set up and considering the densities of the materials 




response was measured and used to calculate the small field angular response correction 
factors.  
The success of the devices and procedures used in the work summarized by this thesis 
shows that these devices (MOSkin and Octa) can verify the delivered dose to targets and 
thus can be confidently adopted into clinical practice. Similarly, the mathematical physics 
formulae and protocols applied allow accurately for phenomenological parameter (such 
as material densities, dose build-up, path length, angular dependence, and accumulation 
of uncertainties) and can therefore be adapted for future QA applications in radiotherapy 
as other new dosimeter devices and systems become progressively available. 
Future work 
 
Implement in clinical practice the MOSkin as a reliable and accurate dosimeter for routine 
real time in vivo skin dosimetry on interfaces and under boluses. For that more 
experiments across different radiation oncology to be carried out. New reader with large 
range of Vth measurements to be developed to extend life span of the MOSkin. 
To implement Octa 2D monolithic dosimeters for machine and patient specific QA to 
routine clinical practice. For that implement obtained angular corrections found for 
application of the Octa in sagittal plane in a cylindrical and in a transverse plane in a spine 
phantom and compare 2D maps predicted by TPS and measured with Octa and EBT film 
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